{
    "id": "dbpedia_1708_2",
    "rank": 33,
    "data": {
        "url": "https://www.urmc.rochester.edu/people/112359745-paul-m-barr",
        "read_more_link": "",
        "language": "en",
        "title": "Paul M. Barr, M.D.",
        "top_image": "https://www.urmc.rochester.edu/ecv_binary/faculty/generated/profile_web/21195.jpg",
        "meta_img": "https://www.urmc.rochester.edu/ecv_binary/faculty/generated/profile_web/21195.jpg",
        "images": [
            "https://www.urmc.rochester.edu/getmedia/2d3c0d22-0eae-4ef9-b5cd-2051e0747bd8/UR-Medicine-logo-svg.svg?maxsidesize=400&resizemode=force",
            "https://www.urmc.rochester.edu/ecv_binary/faculty/generated/profile_web/21195.jpg"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [],
        "publish_date": null,
        "summary": "",
        "meta_description": "The University of Rochester Medical Center (URMC) is one of the nation’s leading academic medical centers. It forms the centerpiece of the University of Rochester’s health research, teaching and patient care missions.\r\n\r\nThe University of Rochester Medical Center is a private, coeducational, nonsectarian, and nonprofit research university.",
        "meta_lang": "en",
        "meta_favicon": "",
        "meta_site_name": "University of Rochester Medical Center",
        "canonical_link": "https://www.urmc.rochester.edu/people/112359745-paul-m-barr",
        "text": "Follow-up from the A041202 study shows continued efficacy of ibrutinib regimens for older adults with CLL.\n\nWoyach JA, Perez Burbano GE, Ruppert AS, Miller CR, Heerema NA, Zhao W, Wall A, Ding W, Bartlett NL, Brander DM, Barr PM, Rogers KA, Parikh SA, Stephens DM, Brown JR, Lozanski G, Blachly JS, Nattam S, Larson RA, Erba HP, Litzow MR, Luger SM, Owen C, Kuzma C, Abramson JS, Little RF, Dinner SN, Stone RM, Uy GL, Stock W, Mandrekar SJ, Byrd JC\n\nBlood.. 2024 April 18143 (16):1616-1627. Epub 1900 01 01.\n\nALK-rearranged CD30-positive poorly differentiated lung adenocarcinoma, mimicking anaplastic large-cell lymphoma.\n\nGeorge GV, Wallace DS, Wang Y, Carney J, Elsadawi M, Burack WR, Evans AG, Barr PM, Velez MJ, El Hussein S\n\nHistopathology.. 2024 April 84 (5):900-902. Epub 11/30/2023.\n\nResponse-adapted, time-limited venetoclax, umbralisib, and ublituximab for relapsed/refractory chronic lymphocytic leukemia.\n\nHill BT, Ma S, Zent CS, Baran AM, Wallace DS, Advani AS, Winter AM, Winter JN, Gordon LI, Karmali R, Liesveld JL, Mulford DA, Rowland C, Bui A, Sportelli P, Miskin HP, Weiss MS, Friedberg JW, Barr PM\n\nBlood advances.. 2024 January 238 (2):378-387. Epub 1900 01 01.\n\nIntegrative analysis of clinicopathological features defines novel prognostic models for mantle cell lymphoma in the immunochemotherapy era: a report from The North American Mantle Cell Lymphoma Consortium.\n\nVose JM, Fu K, Wang L, Mansoor A, Stewart D, Cheng H, Smith L, Yuan J, Qureishi HN, Link BK, Cessna MH, Barr PM, Kahl BS, Mckinney MS, Khan N, Advani RH, Martin P, Goy AH, Phillips TJ, Mehta A, Kamdar M, Crump M, Pro B, Flowers CR, Jacobson CA, Smith SM, Stephens DM, Bachanova V, Jin Z, Wu S, Hernandez-Ilizaliturri F, Torka P, Anampa-Guzmán A, Kashef F, Li X, Sharma S, Greiner TC, Armitage JO, Lunning M, Weisenburger DD, Bociek RG, Iqbal J, Yu G, Bi C,\n\nJournal of hematology & oncology.. 2023 December 1616 (1):122. Epub 12/16/2023.\n\nExpression analysis of pro-apoptotic and anti-apoptotic genes in relation to lactation performance in and crossbred cows.\n\nRaj S R, D N D, Mondal S, Ashokan M, Thota LN, Karuthadurai T, J NKT, Ramesha KP\n\nAnimal biotechnology.. 2023 November 34 (4):1354-1361. Epub 01/22/2022.\n\nNivolumab combined with brentuximab vedotin for R/R primary mediastinal large B-cell lymphoma: a 3-year follow-up.\n\nZinzani PL, Santoro A, Gritti G, Brice P, Barr PM, Kuruvilla J, Cunningham D, Kline J, Johnson NA, Mehta-Shah N, Lisano JM, Wen R, Akyol A, Moskowitz AJ\n\nBlood advances.. 2023 September 267 (18):5272-5280. Epub 1900 01 01.\n\nFirst Double-Differential Measurement of Kinematic Imbalance in Neutrino Interactions with the MicroBooNE Detector.\n\nAbratenko P, Alterkait O, Andrade Aldana D, Anthony J, Arellano L, Asaadi J, Ashkenazi A, Balasubramanian S, Baller B, Barr G, Barrow J, Basque V, Benevides Rodrigues O, Berkman S, Bhanderi A, Bhattacharya M, Bishai M, Blake A, Bogart B, Bolton T, Book JY, Camilleri L, Caratelli D, Caro Terrazas I, Cavanna F, Cerati G, Chen Y, Cohen EO, Conrad JM, Convery M, Cooper-Troendle L, Crespo-Anadón JI, Del Tutto M, Dennis SR, Detje P, Devitt A, Diurba R, Djurcic Z, Dorrill R, Duffy K, Dytman S, Eberly B, Ereditato A, Evans JJ, Fine R, Finnerud OG, Foreman W, Fleming BT, Foppiani N, Franco D, Furmanski AP, Garcia-Gamez D, Gardiner S, Ge G, Gollapinni S, Goodwin O, Gramellini E, Green P, Greenlee H, Gu W, Guenette R, Guzowski P, Hagaman L, Hen O, Hicks R, Hilgenberg C, Horton-Smith GA, Irwin B, Itay R, James C, Ji X, Jiang L, Jo JH, Johnson RA, Jwa YJ, Kalra D, Kamp N, Karagiorgi G, Ketchum W, Kirby M, Kobilarcik T, Kreslo I, Leibovitch MB, Lepetic I, Li JY, Li K, Li Y, Lin K, Littlejohn BR, Louis WC, Luo X, Mariani C, Marsden D, Marshall J, Martinez N, Martinez Caicedo DA, Mason K, Mastbaum A, McConkey N, Meddage V, Miller K, Mills J, Mogan A, Mohayai T, Mooney M, Moor AF, Moore CD, Mora Lepin L, Mousseau J, Mulleriababu S, Naples D, Navrer-Agasson A, Nayak N, Nebot-Guinot M, Nowak J, Oza N, Palamara O, Pallat N, Paolone V, Papadopoulou A, Papavassiliou V, Parkinson HB, Pate SF, Patel N, Pavlovic Z, Piasetzky E, Ponce-Pinto ID, Pophale I, Prince S, Qian X, Raaf JL, Radeka V, Rafique A, Reggiani-Guzzo M, Ren L, Rochester L, Rodriguez Rondon J, Rosenberg M, Ross-Lonergan M, Rudolf von Rohr C, Scanavini G, Schmitz DW, Schukraft A, Seligman W, Shaevitz MH, Sharankova R, Shi J, Snider EL, Soderberg M, Söldner-Rembold S, Spitz J, Stancari M, John JS, Strauss T, Sword-Fehlberg S, Szelc AM, Tang W, Taniuchi N, Terao K, Thorpe C, Torbunov D, Totani D, Toups M, Tsai YT, Tyler J, Uchida MA, Usher T, Viren B, Weber M, Wei H, White AJ, Williams Z, Wolbers S, Wongjirad T, Wospakrik M, Wresilo K, Wright N, Wu W, Yandel E, Yang T, Yates LE, Yu HW, Zeller GP, Zennamo J, Zhang C,\n\nPhysical review letters.. 2023 September 8131 (10):101802. Epub 1900 01 01.\n\nQuality of recovery following childbirth: a prospective, multicentre cohort study.\n\nO'Carroll JE, Zucco L, Warwick E, Arbane G, Moonesinghe SR, El-Boghdadly K, Guo N, Carvalho B, Sultan P,\n\nAnaesthesia.. 2023 September 78 (9):1071-1080. Epub 05/24/2023.\n\nHealthcare Utilization Disparities of Adolescent and Young Adults Compared to the Older Lymphoma Population.\n\nThapa K, Strawderman M, Reagan PM, Barr PM, Zent CS, Friedberg JW, Faugh T, Casulo C\n\nClinical lymphoma, myeloma & leukemia.. 2023 September 23 (9):e260-e267. Epub 05/23/2023.\n\nPhase 2 trial of umbralisib, ublituximab, and venetoclax in patients with relapsed/refractory mantle cell lymphoma.\n\nWallace DS, Rowland C, Hill BT, Baran AM, Casulo C, Reagan PM, Winter A, Karmali R, Winter JN, Gordon LI, Bui A, Sportelli P, Miskin HP, Weiss MS, Friedberg JW, Ma S, Barr PM\n\nLeukemia & lymphoma.. 2023 September 64 (9):1579-1582. Epub 06/21/2023.\n\nUnpacking the CNS Manifestations of Epstein-Barr Virus: An Imaging Perspective.\n\nSoni N, Ora M, Singh R, Mehta P, Agarwal A, Bathla G\n\nAJNR. American journal of neuroradiology.. 2023 September 44 (9):1002-1008. Epub 07/27/2023.\n\nImpact of Bronchiectasis on COPD Severity and Alpha-1 Antitrypsin Deficiency as a Risk Factor in Individuals with a Heavy Smoking History.\n\nIzquierdo M, Marion CR, Genese F, Newell JD, O'Neal WK, Li X, Hawkins GA, Barjaktarevic I, Barr RG, Christenson S, Cooper CB, Couper D, Curtis J, Han MK, Hansel NN, Kanner RE, Martinez FJ, Paine R, Tejwani V, Woodruff PG, Zein JG, Hoffman EA, Peters SP, Meyers DA, Bleecker ER, Ortega VE,\n\nChronic obstructive pulmonary diseases.. 2023 July 2610 (3):199-210. Epub 1900 01 01.\n\nOutcomes in Patients with High-Risk Features after Fixed-Duration Ibrutinib plus Venetoclax: Phase II CAPTIVATE Study in First-Line Chronic Lymphocytic Leukemia.\n\nAllan JN, Flinn IW, Siddiqi T, Ghia P, Tam CS, Kipps TJ, Barr PM, Elinder Camburn A, Tedeschi A, Badoux XC, Jacobs R, Kuss BJ, Trentin L, Zhou C, Szoke A, Abbazio C, Wierda WG\n\nClinical cancer research : an official journal of the American Association for Cancer Research.. 2023 July 1429 (14):2593-2601. Epub 1900 01 01.\n\nTreatment Discontinuation Patterns for Patients With Chronic Lymphocytic Leukemia in Real-World Settings: Results From a Multi-Center International Study.\n\nShadman M, Manzoor BS, Sail K, Tuncer HH, Allan JN, Ujjani C, Emechebe N, Kamalakar R, Coombs CC, Leslie L, Barr PM, Brown JR, Eyre TA, Rampotas A, Schuh A, Lamanna N, Skarbnik A, Roeker LE, Bannerji R, Eichhorst B, Fleury I, Davids MS, Alhasani H, Jiang D, Hill BT, Schuster SJ, Brander DM, Pivneva I, Burne R, Guerin A, Mato AR\n\nClinical lymphoma, myeloma & leukemia.. 2023 July 23 (7):515-526. Epub 03/24/2023.\n\nDietary Patterns Are Not Associated With Disease Activity Among Patients With Inflammatory Conditions of the Pouch in a Prospective Cohort.\n\nBarnes EL, Beniwal-Patel P, Deepak P, Raffals L, Kayal M, Dubinsky M, Chang S, Higgins PDR, Barr JI, Anderson C, Cross RK, Long MD, Herfarth HH\n\nCrohn's & colitis 360.. 2023 July 5 (3):otad039. Epub 07/27/2023.\n\nAcalabrutinib and high-frequency low-dose subcutaneous rituximab for initial therapy of chronic lymphocytic leukemia.\n\nWallace DS, Zent CS, Baran AM, Reagan PM, Casulo C, Rice G, Friedberg JW, Barr PM\n\nBlood advances.. 2023 June 137 (11):2496-2503. Epub 1900 01 01.\n\nCD138- Plasmablastic Lymphoma: A Multi-institutional Study and Review of the Literature.\n\nChoudhuri J, Pan Z, Yuan J, Chen M, Wu X, Zheng G, Zhao C, Yuan Y, Agarwal B, Liu J, Ma MY, Wang Y, Shi Y\n\nArchives of pathology & laboratory medicine.. 2023 June 1147 (6):643-654. Epub 1900 01 01.\n\nDevelopment of the Endoscopic Pouch Score for Assessment of Inflammatory Conditions of the Pouch.\n\nBarnes EL, Long MD, Raffals L, Isaacs K, Stidham RW, Herfarth HH,\n\nClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.. 2023 June 21 (6):1663-1666.e3. Epub 05/12/2022.\n\nRituximab induced cytokine release with high serum IP-10 (CXCL10) concentrations is associated with infusion reactions.\n\nMoore JE, Bloom PC, Chu CC, Bruno JE, Herne CA, Baran AM, Quataert SA, Mosmann TR, Taylor RP, Wallace DS, Elliott MR, Barr PM, Zent CS\n\nLeukemia research.. 2023 June 129 :107072. Epub 03/29/2023.\n\nCurrent Concepts in Nodal Peripheral T-Cell Lymphomas.\n\nOishi N, Feldman AL\n\nSurgical pathology clinics.. 2023 June 16 (2):267-285. Epub 04/03/2023.\n\nLiver Fibrosis, Fat, and Iron Evaluation with MRI and Fibrosis and Fat Evaluation with US: A Practical Guide for Radiologists.\n\nGuglielmo FF, Barr RG, Yokoo T, Ferraioli G, Lee JT, Dillman JR, Horowitz JM, Jhaveri KS, Miller FH, Modi RY, Mojtahed A, Ohliger MA, Pirasteh A, Reeder SB, Shanbhogue K, Silva AC, Smith EN, Surabhi VR, Taouli B, Welle CL, Yeh BM, Venkatesh SK\n\nRadiographics : a review publication of the Radiological Society of North America, Inc.. 2023 June 43 (6):e220181. Epub 1900 01 01.\n\nPrimary hepatic Epstein-Barr virus-positive diffuse large B-cell lymphoma associated with azathioprine immunosuppression: a case report.\n\nMarell PS, Shi M, Wingo MT\n\nJournal of medical case reports.. 2023 May 217 (1):175. Epub 05/02/2023.\n\nExosomes, microvesicles, and other extracellular vesicles-a Keystone Symposia report.\n\nCable J, Witwer KW, Coffey RJ, Milosavljevic A, von Lersner AK, Jimenez L, Pucci F, Barr MM, Dekker N, Barman B, Humphrys D, Williams J, de Palma M, Guo W, Bastos N, Hill AF, Levy E, Hantak MP, Crewe C, Aikawa E, Adamczyk AM, Zanotto TM, Ostrowski M, Arab T, Rabe DC, Sheikh A, da Silva DR, Jones JC, Okeoma C, Gaborski T, Zhang Q, Gololobova O\n\nAnnals of the New York Academy of Sciences.. 2023 May 1523 (1):24-37. Epub 03/18/2023.\n\nSelective Bcl-2 inhibition promotes hematopoietic chimerism and allograft tolerance without myelosuppression in nonhuman primates.\n\nSasaki H, Hirose T, Oura T, Otsuka R, Rosales I, Ma D, Lassiter G, Karadagi A, Tomosugi T, Dehnadi A, Matsunami M, Raju Paul S, Reeves PM, Hanekamp I, Schwartz S, Colvin RB, Lee H, Spitzer TR, Cosimi AB, Cippà PE, Fehr T, Kawai T\n\nScience translational medicine.. 2023 April 515 (690):eadd5318. Epub 04/05/2023.\n\nGuidelines to Establish an Equitable Mobile Health Ecosystem.\n\nFortuna KL, Kadakia A, Cosco TD, Rotondi A, Nicholson J, Mois G, Myers AL, Hamilton J, Brewer LC, Collins-Pisano C, Barr P, Hudson MF, Joseph K, Mullaly C, Booth M, Lebby S, Walker R\n\nPsychiatric services : a journal of the American Psychiatric Association.. 2023 April 174 (4):393-400. Epub 11/15/2022.\n\nCharacterization of primary cutaneous T-cell lymphoma following solid organ transplantation.\n\nShimshak S, Dai C, Comfere N, Sokumbi O\n\nInternational journal of dermatology.. 2023 April 62 (4):494-500. Epub 06/10/2022.\n\nA phase 1b study of ibrutinib in combination with obinutuzumab in patients with relapsed or refractory chronic lymphocytic leukemia.\n\nRyan CE, Brander DM, Barr PM, Tyekucheva S, Hackett LR, Collins MC, Fernandes SM, Ren Y, Zhou Y, McDonough MM, Walker HA, McEwan MR, Abramson JS, Jacobsen ED, LaCasce AS, Fisher DC, Brown JR, Davids MS\n\nLeukemia.. 2023 April 37 (4):835-842. Epub 01/30/2023.\n\nAberrant activation of TCL1A promotes stem cell expansion in clonal haematopoiesis.\n\nWeinstock JS, Gopakumar J, Burugula BB, Uddin MM, Jahn N, Belk JA, Bouzid H, Daniel B, Miao Z, Ly N, Mack TM, Luna SE, Prothro KP, Mitchell SR, Laurie CA, Broome JG, Taylor KD, Guo X, Sinner MF, von Falkenhausen AS, Kääb S, Shuldiner AR, O'Connell JR, Lewis JP, Boerwinkle E, Barnes KC, Chami N, Kenny EE, Loos RJF, Fornage M, Hou L, Lloyd-Jones DM, Redline S, Cade BE, Psaty BM, Bis JC, Brody JA, Silverman EK, Yun JH, Qiao D, Palmer ND, Freedman BI, Bowden DW, Cho MH, DeMeo DL, Vasan RS, Yanek LR, Becker LC, Kardia SLR, Peyser PA, He J, Rienstra M, Van der Harst P, Kaplan R, Heckbert SR, Smith NL, Wiggins KL, Arnett DK, Irvin MR, Tiwari H, Cutler MJ, Knight S, Muhlestein JB, Correa A, Raffield LM, Gao Y, de Andrade M, Rotter JI, Rich SS, Tracy RP, Konkle BA, Johnsen JM, Wheeler MM, Smith JG, Melander O, Nilsson PM, Custer BS, Duggirala R, Curran JE, Blangero J, McGarvey S, Williams LK, Xiao S, Yang M, Gu CC, Chen YI, Lee WJ, Marcus GM, Kane JP, Pullinger CR, Shoemaker MB, Darbar D, Roden DM, Albert C, Kooperberg C, Zhou Y, Manson JE, Desai P, Johnson AD, Mathias RA, , Blackwell TW, Abecasis GR, Smith AV, Kang HM, Satpathy AT, Natarajan P, Kitzman JO, Whitsel EA, Reiner AP, Bick AG, Jaiswal S\n\nNature.. 2023 April 616 (7958):755-763. Epub 04/12/2023.\n\nClinical course and features of persistent polyclonal B-cell lymphocytosis with BCL-6 amplification during pregnancy.\n\nGalitzia A, Murru R, Caocci G, Barabino L, Azzena A, Licheri VM, Greco M, La Nasa G\n\nEuropean review for medical and pharmacological sciences.. 2023 April 27 (8):3514-3518. Epub 1900 01 01.\n\nReactivation of Parvovirus B19 Infection: An Uncommon Trigger of Macrophage Activation Syndrome in Adult-Onset Still's Disease.\n\nLeelaviwat N, Armin S, Mekraksakit P, Nugent K\n\nCure?us.. 2023 April 15 (4):e37231. Epub 04/06/2023.\n\nHemophagocytic Lymphohistiocytosis: an Under-recognized and Life-threatening Condition.\n\nPoudyal BS, Poudel B, Tuladhar S, Rijal SS, Shrestha GS, Joshi U\n\nJournal of Nepal Health Research Council.. 2023 March 1020 (3):794-796. Epub 03/10/2023.\n\nMinimuMM-seq: Genome Sequencing of Circulating Tumor Cells for Minimally Invasive Molecular Characterization of Multiple Myeloma Pathology.\n\nDutta AK, Alberge JB, Lightbody ED, Boehner CJ, Dunford A, Sklavenitis-Pistofidis R, Mouhieddine TH, Cowan AN, Su NK, Horowitz EM, Barr H, Hevenor L, Beckwith JB, Perry J, Cao A, Lin Z, Kuhr FK, Del Mastro RG, Nadeem O, Greipp PT, Stewart C, Auclair D, Getz G, Ghobrial IM\n\nCancer discovery.. 2023 February 613 (2):348-363. Epub 1900 01 01.\n\nMOG and AQP4 Antibodies among Children with Multiple Sclerosis and Controls.\n\nGaudioso CM, Mar S, Casper TC, Codden R, Nguyen A, Aaen G, Benson L, Chitnis T, Francisco C, Gorman MP, Goyal MS, Graves J, Greenberg BM, Hart J, Krupp L, Lotze T, Narula S, Pittock SJ, Rensel M, Rodriguez M, Rose J, Schreiner T, Tillema JM, Waldman A, Weinstock-Guttman B, Wheeler Y, Waubant E, Flanagan EP,\n\nAnnals of neurology.. 2023 February 93 (2):271-284. Epub 10/04/2022.\n\nDiscovery of a potent Guanidine derivative that selectively binds and stabilizes the human BCL-2 G-quadruplex DNA and downregulates the transcription.\n\nPandya N, Rani R, Kumar V, Kumar A\n\nGene.. 2023 January 30851 :146975. Epub 10/17/2022.\n\nCharacteristics and Clinical Outcomes of Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Receiving Ibrutinib for ?5 Years in the RESONATE-2 Study.\n\nWoyach JA, Barr PM, Kipps TJ, Barrientos JC, Ahn IE, Ghia P, Girardi V, Hsu E, Jermain M, Burger JA\n\nCancers.. 2023 January 1315 (2)Epub 01/13/2023.\n\nRelevance of Bone Marrow Biopsies for Response Assessment in US National Cancer Institute National Clinical Trials Network Follicular Lymphoma Clinical Trials.\n\nRutherford SC, Yin J, Pederson L, Perez Burbano G, LaPlant B, Shadman M, Li H, LeBlanc ML, Kenkre VP, Hong F, Blum KA, Dockter T, Martin P, Jung SH, Grant B, Rosenbaum C, Ujjani C, Barr PM, Unger JM, Cheson BD, Bartlett NL, Kahl B, Friedberg JW, Mandrekar SJ, Leonard JP\n\nJournal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2023 January 1041 (2):336-342. Epub 07/05/2022.\n\nGenetic and immunohistochemical profiling of NK/T-cell lymphomas reveals prognostically relevant BCOR-MYC association.\n\nOishi N, Satou A, Miyaoka M, Kawashima I, Segawa T, Miyake K, Mochizuki K, Kirito K, Feldman A, Nakamura N, Kondo T\n\nBlood advances.. 2023 January 107 (1):178-189. Epub 1900 01 01.\n\nMany People With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Benefit From Ibrutinib Treatment Up To 8 Years: A Plain Language Summary.\n\nBarr PM, Owen C, Robak T, Tedeschi A, Bairey O, Burger JA, Hillmen P, Dearden C, Grosicki S, McCarthy H, Li JY, Offner F, Moreno C, Jermain M, Zhou C, Hsu E, Szoke A, Kipps TJ, Ghia P\n\nFuture oncology.. 2023 January 9 Epub 01/09/2023.\n\nFirst Constraints on Light Sterile Neutrino Oscillations from Combined Appearance and Disappearance Searches with the MicroBooNE Detector.\n\nAbratenko P, Andrade Aldana D, Anthony J, Arellano L, Asaadi J, Ashkenazi A, Balasubramanian S, Baller B, Barr G, Barrow J, Basque V, Bathe-Peters L, Benevides Rodrigues O, Berkman S, Bhanderi A, Bhattacharya M, Bishai M, Blake A, Bogart B, Bolton T, Book JY, Camilleri L, Caratelli D, Caro Terrazas I, Cavanna F, Cerati G, Chen Y, Conrad JM, Convery M, Cooper-Troendle L, Crespo-Anadón JI, Del Tutto M, Dennis SR, Detje P, Devitt A, Diurba R, Dorrill R, Duffy K, Dytman S, Eberly B, Ereditato A, Evans JJ, Fine R, Finnerud OG, Foreman W, Fleming BT, Foppiani N, Franco D, Furmanski AP, Garcia-Gamez D, Gardiner S, Ge G, Gollapinni S, Goodwin O, Gramellini E, Green P, Greenlee H, Gu W, Guenette R, Guzowski P, Hagaman L, Hen O, Hicks R, Hilgenberg C, Horton-Smith GA, Irwin B, Itay R, James C, Ji X, Jiang L, Jo JH, Johnson RA, Jwa YJ, Kalra D, Kamp N, Karagiorgi G, Ketchum W, Kirby M, Kobilarcik T, Kreslo I, Leibovitch MB, Lepetic I, Li JY, Li K, Li Y, Lin K, Littlejohn BR, Louis WC, Luo X, Manivannan K, Mariani C, Marsden D, Marshall J, Martinez N, Martinez Caicedo DA, Mason K, Mastbaum A, McConkey N, Meddage V, Miller K, Mills J, Mogan A, Mohayai T, Mooney M, Moor AF, Moore CD, Mora Lepin L, Mousseau J, Mulleriababu S, Naples D, Navrer-Agasson A, Nayak N, Nebot-Guinot M, Nowak J, Nunes M, Oza N, Palamara O, Pallat N, Paolone V, Papadopoulou A, Papavassiliou V, Parkinson HB, Pate SF, Patel N, Pavlovic Z, Piasetzky E, Ponce-Pinto ID, Pophale I, Prince S, Qian X, Raaf JL, Radeka V, Reggiani-Guzzo M, Ren L, Rochester L, Rodriguez Rondon J, Rosenberg M, Ross-Lonergan M, Rudolf von Rohr C, Scanavini G, Schmitz DW, Schukraft A, Seligman W, Shaevitz MH, Sharankova R, Shi J, Smith A, Snider EL, Soderberg M, Söldner-Rembold S, Spitz J, Stancari M, St John J, Strauss T, Sword-Fehlberg S, Szelc AM, Tang W, Taniuchi N, Terao K, Thorpe C, Torbunov D, Totani D, Toups M, Tsai YT, Tyler J, Uchida MA, Usher T, Viren B, Weber M, Wei H, White AJ, Williams Z, Wolbers S, Wongjirad T, Wospakrik M, Wresilo K, Wright N, Wu W, Yandel E, Yang T, Yates LE, Yu HW, Zeller GP, Zennamo J, Zhang C,\n\nPhysical review letters.. 2023 January 6130 (1):011801. Epub 1900 01 01.\n\nAdapting investigational drug services during a pandemic: Recommendations for future preparedness from the Hematology/Oncology Pharmacy Association Investigational Drug Services Special Interest Group.\n\nFinnes HD, Child B, DeFrates S, Kinsman K, Thorne A, Lentz S, Lockhorst R, Murphy J, Urmanski A, Amin S, Barr H, Baviskar S, Beckman C, Chow N, Derba M, Erickson M, Hennes E, Heisey H, Lau R, Limvorasak S, Luckritz T, Mays T, Nzelibe CN, Romanowski T, Smith C, Tesoro D, Toeniskoetter K, Voytilla K\n\nAmerican journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.. 2023 January 180 (1):e67-e73. Epub 1900 01 01.\n\nImmune dysregulation.\n\nLong A, Kleiner A, Looney RJ\n\nThe Journal of allergy and clinical immunology.. 2023 January 151 (1):70-80. Epub 1900 01 01.\n\nCanadian Spine Society: 23rd Annual Scientific Conference, Wednesday, March 1 - Saturday, March 4, Fairmont Le Château Frontenac, Québec, Que., Canada.\n\nBirk M, Sidhu K, Filezio MR, Singh V, Ferri-de-Barros F, Chan V, Shumilak G, Nataraj A, Langston H, Yee NJ, Iorio C, Shkumat N, Rocos B, Ertl-Wagner B, Lebel D, Camp MW, Dimentberg E, Saran N, Laflamme M, Ouellet JA, Wenghofer J, Livock H, Beaton L, Tice A, Smit K, Graham R, Duarte MP, Roy-Beaudry M, Turgeon I, Joncas J, Mac-Thiong JM, Labelle H, Barchi S, Parent S, Gholamian T, Livock H, Tice A, Smit K, Yoon S, Zulfiqar A, Rocos B, Murphy A, Bath N, Moll S, Sorbara J, Lebel D, Camp MW, Nallet JA, Rocos B, Lebel DE, Zeller R, Dermott JA, Kim DJ, Anthony A, Zeller R, Lebel DE, Wang Z, Shen J, Kamel Y, Liu J, Shedid D, Al-Shakfa F, Yuh SJ, Boubez G, Rizkallah M, Rizkallah M, Shen J, Boubez G, Kamel Y, Liu J, Shedid D, Al-Shakfa F, Lavoie F, Yug SJ, Wang Z, Alavi F, Nielsen C, Rampersaud R, Lewis S, Cheung AM, Cadieux C, Fernandes R, Brzozowski P, Zdero R, Bailey C, Rasoulinejad P, Cherry A, Manoharan R, Xu M, Srikandarajah N, Iorio C, Raj A, Nielsen C, Rampersaud R, Lewis S, Beange K, Graham R, Livock H, Smit K, Manoharan R, Cherry A, Srikandarajah N, Raj A, Xu M, Iorio C, Nielsen CJ, Rampersaud YR, Lewis SJ, Nasrabadi AAM, Moammer G, Phee JM, Walker T, Urquhart JC, Glennie RA, Rampersaud YR, Fisher CG, Bailey CS, Herrington BJ, Fernandes RR, Urquhart JC, Rasoulinejad P, Siddiqi F, Bailey CS, Urquhart J, Fernandes RR, Glennie RA, Rampersaud YR, Fisher CG, Bailey CS, Yang MMH, Riva-Cambrin J, Cunningham J, Casha S, Cadieux CN, Urquhart J, Fernandes R, Glennie A, Fisher C, Rampersaud R, Xu M, Manoharan R, Cherry A, Raj A, Srikandarajah N, Iorio C, Nielsen C, Lewis S, Rampersaud R, Cherry A, Raj A, McIntosh G, Manoharan R, Murray JC, Nielsen C, Xu M, Srikandarajah N, Iorio C, Perruccio A, Canizares M, Rampersaud R, El-Mughayyar D, Bigney E, Richardson E, Manson N, Abraham E, Attabib N, Small C, Kolyvas G, LeRoux A, Outcomes CS, Investigators RN, Hebert J, Baisamy V, Rizkallah M, Shen J, Cresson T, Vazquez C, Wang Z, Boubez G, Lung T, Canizares M, Perruccio A, Rampersaud R, Crawford EJ, Ravinsky RA, Perruccio AV, Rampersaud YR, Coyte PC, Bond M, Street J, Fisher C, Charest-Morin R, Sutherland JM, Bartolozzi AR, Barzilai O, Chou D, Laufer I, Verlaan JJ, Sahgal A, Rhines LD, Scuibba DM, Lazary A, Weber MH, Schuster JM, Boriani S, Bettegowda C, Arnold PM, Clarke MJ, Fehlings MG, Reynolds JJ, Gokaslan ZL, Fisher CG, Dea N, Versteeg AL, Charest-Morin R, Laufer I, Teixeira W, Barzilai O, Gasbarrini A, Fehlings MG, Chou D, Johnson MG, Gokaslan ZL, Dea N, Verlaan JJ, Goldschlager T, Shin JH, O'Toole JE, Sciubba DM, Bettegowda C, Clarke MJ, Weber MH, Mesfin A, Kawahara N, Goodwin R, Disch A, Lazary A, Boriani S, Sahgal A, Rhines L, Fisher CG, Versteeg AL, Gal R, Reich L, Tsang A, Aludino A, Sahgal A, Verlaan JJ, Fisher CG, Verkooijen L, Rizkallah M, Wang Z, Yuh SJ, Shedid D, Shen J, Al-Shakfa F, Belguendouz C, AlKafi R, Boubez G, MacLean MA, Georgiopoulos M, Charest-Morin R, Germscheid N, Goodwin CR, Weber M, International AS, Rizkallah M, Boubez G, Zhang H, Al-Shakfa F, Brindamour P, Boule D, Shen J, Shedid D, Yuh SJ, Wang Z, Correale MR, Soever LJ, Rampersaud R, Malic CC, Dubreuil M, Duke K, Kingwell SP, Lin Z, MacLean MA, Julien LC, Patriquin G, LeBlanc J, Green R, Alant J, Barry S, Glennie RA, Oxney W, Christie SD, Sarraj M, Alqahtani A, Thornley P, Koziarz F, Bailey CS, Freire-Archer M, Bhanot K, Kachur E, Bhandari M, Oitment C, Malhotra AK, Balas M, Jaja BNR, Harrington EM, Hofereiter J, Jaffe RH, He Y, Byrne JP, Wilson JR, Witiw CD, Brittain KCM, Christie S, Pillai S, Dvorak MF, Evaniew N, Chen M, Waheed Z, Rotem-Kohavi N, Fallah N, Noonan VK, Fisher CG, Charest-Morin R, Dea N, Ailon T, Street J, Kwon BK, Sandarage RV, Galuta A, Ghinda D, Kwan JCS, TsaI EC, Hachem LD, Hong J, Velumian A, Mothe AJ, Tator CH, Fehlings MG, Shakil H, Jaja BNR, Zhang P, Jaffe R, Malhotra AK, Wilson JR, Witiw CD, Rotem-Kohavi N, Dvorak MF, Dea N, Evaniew N, Chen M, Waheed Z, Xu J, Fallah N, Noonan V, Kwon B, Dandurand C, Muijs S, Dvorak M, Schnake K, Cumhur , Ouml Ner , Greene R, Furlong B, Smith-Forrester J, Swab M, Christie SD, Hall A, Leck E, Marshall E, Christie S, Dvorak MF, Cumhur F, Ouml Ner , Vaccaro AR, Benneker LM, Rajasekaran S, El-Sharkawi M, Popescu EC, Tee JW, Paquet J, France JC, Allen R, Lavelle WF, Hirschfeld M, Pneumaticos S, Dandurand C, Cumhur , Ouml Ner , Muijs S, Schnake K, Dvorak M, Fernandes RR, Thornley P, Urquhart J, Kelly S, Alenezi N, Alahmari A, Siddiqi F, Singh S, Rasoulinejad P, Bailey C, Evaniew N, Burger LD, Dea N, Cadotte DW, McIntosh G, Jacobs B, St-Laurent-Lebeux L, Bourassa-Moreau É, Sarraj M, Majeed M, Guha D, Pahuta M, Laflamme M, McIntosh G, Dea N, Bak AB, Alvi MA, Moghaddamjou A, Fehlings MG, Silva YGMD, Goulet J, McIntosh G, Bedard S, Pimenta N, Blanchard J, Couture J, LaRue B, Investigators C, Adams T, Cunningham E, El-Mughayyar D, Bigney E, Vandewint A, Manson N, Abraham E, Small C, Attabib N, Richardson E, Hebert J, Bond M, Street J, Fisher C, Charest-Morin R, Sutherland JM, Hillier T, Bailey CS, Fisher C, Rampersaud R, Koto P, Glennie RA, Soroceanu A, Nicholls F, Thomas K, Evaniew N, Lewkonia P, Bouchard J, Jacobs B, Ben-Israel D, Crawford EJ, Fisher C, Dea N, Spackman E, Rampersaud R, Thomas KC, Srikandarajah N, Murray JC, Nielsen C, Manoharan R, Cherry A, Raj A, Xu M, Iorio C, Bailey C, Dea N, Fisher C, Hall H, Manson N, Thomas K, Canizares M, Rampersaud YR, Urquhart J, Fernandes RR, Glennie RA, Rampersaud YR, Fisher CG, Bailey C, Yang MMH, Far R, Sajobi T, Riva-Cambrin J, Casha S, Bond M, Street J, Fisher C, Charest-Morin R, Sutherland JM, Silva Y, Pimenta NG, LaRue B, Bedard S, Oviedo SC, Goulet J, Couture J, Blanchard J, McDonald J, Al-Jahdali F, Urquhart J, Alahmari A, Rampersaud R, Fisher C, Bailey C, Glennie A, Evaniew N, Coyle M, Rampersaud YR, Bailey CS, Jacobs WB, Cadotte DW, Thomas KC, Attabib N, Paquet J, Nataraj A, Christie SD, Weber MH, Phan P, Charest-Morin R, Fisher CG, Hall H, McIntosh G, Dea N, Malhotra AK, Davis AM, He Y, Harrington EM, Jaja BNR, Zhu MP, Shakil H, Dea N, Jacobs WB, Cadotte DW, Paquet J, Weber MH, Phan P, Christie SD, Nataraj A, Bailey CS, Johnson MG, Fisher CG, Manson N, Rampersaud YR, Thomas KC, Hall H, Fehlings MG, Ahn H, Ginsberg HJ, Witiw CD, Wilson JR, Althagafi A, McIntosh G, Charest-Morin R, Rizzuto MA, Ailon T, Dea N, Evaniew N, Jacobs BW, Paquet J, Rampersaud R, Hall H, Bailey CS, Weber M, Johnson MG, Nataraj A, Attabib N, Cadotte DW, Manson N, Stratton A, Christie SD, Thomas KC, Wilson JR, Fisher CG, Charest-Morin R, Bak AB, Alvi MA, Moghaddamjou A, Fehlings MG, Bak AB, Alvi MA, Moghaddamjou A, Fehlings MG, Soroceanu A, Nicholls F, Thomas K, Evaniew N, Salo P, Bouchard J, Jacobs B, Dandurand C, Laghaei PF, Ailon T, Charest-Morin R, Dea N, Dvorak M, Fisher C, Kwon BK, Paquette S, Street J, Soroceanu A, Nicholls F, Thomas K, Evaniew N, Bouchard J, Salo P, Jacobs B, Varshney VP, Sahjpaul R, Paquette S, Osborn J, Bak AB, Moghaddamjou A, Fehlings MG, Leck E, Marshall E, Christie S, Elkaim LM, Lasry OJ, Raj A, Murray JC, Cherry A, McIntosh G, Nielsen C, Srikandarajah N, Manoharan R, Iorio C, Xu M, Perruccio A, Canizares M, Rampersaud YR, Stratton A, Tierney S, Wai EK, Phan P, Kingwell S, Magnan MC, Soroceanu A, Nicholls F, Thomas K, Evaniew N, Salo P, Bouchard J, Jacobs B, Spanninga B, Hoelen TA, Johnson S, Arts JJC, Bailey CS, Urquhart JC, Glennie RA, Rampersaud YR, Fisher CG, Levett JJ, Elkaim LM, Alotaibi NM, Weber MH, Dea N, Abd-El-Barr MM, Cherry A, Yee A, Jaber N, Fehlings M, Cunningham E, Adams T, El-Mughayyar D, Bigney E, Vandewint A, Manson N, Abraham E, Small C, Attabib N, Richardson E, Hebert J, Werier J, Smit K, Villeneuve J, Sachs A, Abdelbary H, Al-Mosuli YK, Rakhra K, Phan P, Nagata K, Gum JL, Brown ME, Daniels CL, Carreon LY, Bonello JP, Koucheki R, Abbas A, Lex J, Nucci N, Whyne C, Larouche J, Ahn H, Finkelstein J, Lewis S, Toor J, Lee NJ, Orosz LD, Gum JL, Poulter GT, Jazini E, Haines CM, Good CR, Lehman RA, Crawford EJ, Ravinsky RA, Perruccio AV, Coyte PC, Rampersaud YR, Freire-Archer M, Sarraj M, AlShaalan F, Koziarz A, Thornley P, Alnemari H, Oitment C, Bharadwaj L, El-Mughayyar D, Bigney E, Manson N, Abraham E, Small C, Attabib N, Richardson E, Kearney J, Kundap U, Investigators C, Hebert J, Elkaim LM, Levett JJ, Niazi F, Bokhari R, Alotaibi NM, Lasry OJ, Bissonnette V, Yen D, Muddaluru VS, Gandhi P, Mastrolonardo A, Guha D, Pahuta MA, Christie SD, Vandertuin T, Ritcey G, Rainham D, Alhawsawi M, Mumtaz R, Abdelnour M, Qumquji F, Soroceanu A, Swamy G, Thomas K, Wai E, Phan P, Bhatt FR, Orosz LD, Yamout T, Good CR, Schuler TC, Nguyen T, Jazini E, Haines CM, Oppermann M, Gupta S, Ramjist J, Oppermann PS, Yang VXD, Levett JJ, Elkaim LM, Niazi F, Weber MH, Ioro-Morin C, Bonizzato M, Weil AG, Oppermann M, Ramjist J, Gupta S, Oppermann PS, Yang VXD, Jung Y, Muddalaru V, Gandhi P, Guha D, Koucheki R, Bonello JP, Abbas A, Lex JR, Nucci N, Whyne C, Yee A, Ahn H, Finkelstein J, Larouche J, Lewis S, Toor J, Dhawan A, Dhawan J, Sharma AN, Azzam DB, Cherry A, Fehlings MG, Orosz LD, Lee NJ, Yamout T, Gum JL, Lehman RA, Poulter GT, Haines CM, Jazini E, Good CR, Ridha BB, Persad A, Fourney D, Byers E, Gallagher M, Sugar J, Brown JL, Wang Z, Shen J, Boubez G, Al-Shakfa F, Yuh SJ, Shedid D, Rizkallah M, Singh M, Singh PK, Lawrence PL, Dell S, Goodluck-Tyndall R, Wade K, Morgan M, Bruce C, Silva YGMD, Pimenta N, LaRue B, Aldakhil S, Blanchard J, Couture J, Goulet J, Bednar DA, Raj R, Urquhart J, Bailey C, Christie SD, Greene R, Chaves JPG, Zarrabian M, Sigurdson L, Manoharan R, Cherry A, Iorio C, Srikandarajah N, Xu M, Raj A, Nielsen CJ, Rampersaud YR, Lewis SJ\n\nCanadian journal of surgery. Journal canadien de chirurgie.. 2023 66 (4 Suppl 1):S1-S53. Epub 08/11/2023.\n\nMeasurements of neutrino oscillation parameters from the T2K experiment using protons on target.\n\nAbe K, Akhlaq N, Akutsu R, Ali A, Alonso Monsalve S, Alt C, Andreopoulos C, Antonova M, Aoki S, Arihara T, Asada Y, Ashida Y, Atkin ET, Barbi M, Barker GJ, Barr G, Barrow D, Batkiewicz-Kwasniak M, Bench F, Berardi V, Berns L, Bhadra S, Blanchet A, Blondel A, Bolognesi S, Bonus T, Bordoni S, Boyd SB, Bravar A, Bronner C, Bron S, Bubak A, Buizza Avanzini M, Caballero JA, Calabria NF, Cao S, Carabadjac D, Carter AJ, Cartwright SL, Catanesi MG, Cervera A, Chakrani J, Cherdack D, Chong PS, Christodoulou G, Chvirova A, Cicerchia M, Coleman J, Collazuol G, Cook L, Cudd A, Dalmazzone C, Daret T, Davydov YI, De Roeck A, De Rosa G, Dealtry T, Delogu CC, Densham C, Dergacheva A, Di Lodovico F, Dolan S, Douqa D, Doyle TA, Drapier O, Dumarchez J, Dunne P, Dygnarowicz K, Eguchi A, Emery-Schrenk S, Erofeev G, Ershova A, Eurin G, Fedorova D, Fedotov S, Feltre M, Finch AJ, Fiorentini Aguirre GA, Fiorillo G, Fitton MD, Franco Patiño JM, Friend M, Fujii Y, Fukuda Y, Fusshoeller K, Giannessi L, Giganti C, Glagolev V, Gonin M, González Rosa J, Goodman EAG, Gorin A, Grassi M, Guigue M, Hadley DR, Haigh JT, Hamacher-Baumann P, Harris DA, Hartz M, Hasegawa T, Hassani S, Hastings NC, Hayato Y, Henaff D, Hiramoto A, Hogan M, Holeczek J, Holin A, Holvey T, Hong Van NT, Honjo T, Iacob F, Ichikawa AK, Ikeda M, Ishida T, Ishitsuka M, Israel HT, Iwamoto K, Izmaylov A, Izumi N, Jakkapu M, Jamieson B, Jenkins SJ, Jesús-Valls C, Jiang JJ, Jonsson P, Joshi S, Jung CK, Jurj PB, Kabirnezhad M, Kaboth AC, Kajita T, Kakuno H, Kameda J, Kasetti SP, Kataoka Y, Katayama Y, Katori T, Kawaue M, Kearns E, Khabibullin M, Khotjantsev A, Kikawa T, Kikutani H, King S, Kiseeva V, Kisiel J, Kobata T, Kobayashi H, Kobayashi T, Koch L, Kodama S, Konaka A, Kormos LL, Koshio Y, Kostin A, Koto T, Kowalik K, Kudenko Y, Kudo Y, Kuribayashi S, Kurjata R, Kutter T, Kuze M, La Commara M, Labarga L, Lachner K, Lagoda J, Lakshmi SM, Lamers James M, Lamoureux M, Langella A, Laporte JF, Last D, Latham N, Laveder M, Lavitola L, Lawe M, Lee Y, Lin C, Lin SK, Litchfield RP, Liu SL, Li W, Longhin A, Long KR, Lopez Moreno A, Ludovici L, Lu X, Lux T, Machado LN, Magaletti L, Mahn K, Malek M, Mandal M, Manly S, Marino AD, Marti-Magro L, Martin DGR, Martini M, Martin JF, Maruyama T, Matsubara T, Matveev V, Mauger C, Mavrokoridis K, Mazzucato E, McCauley N, McElwee J, McFarland KS, McGrew C, McKean J, Mefodiev A, Megias GD, Mehta P, Mellet L, Metelko C, Mezzetto M, Miller E, Minamino A, Mineev O, Mine S, Miura M, Molina Bueno L, Moriyama S, Moriyama S, Morrison P, Mueller TA, Munford D, Munteanu L, Nagai K, Nagai Y, Nakadaira T, Nakagiri K, Nakahata M, Nakajima Y, Nakamura A, Nakamura H, Nakamura K, Nakamura KD, Nakano Y, Nakayama S, Nakaya T, Nakayoshi K, Naseby CER, Ngoc TV, Nguyen VQ, Niewczas K, Nishimori S, Nishimura Y, Nishizaki K, Nosek T, Nova F, Novella P, Nugent JC, O'Keeffe HM, O'Sullivan L, Odagawa T, Ogawa T, Okada R, Okinaga W, Okumura K, Okusawa T, Ospina N, Owen RA, Oyama Y, Palladino V, Paolone V, Pari M, Parlone J, Parsa S, Pasternak J, Pavin M, Payne D, Penn GC, Pershey D, Pickering L, Pidcott C, Pintaudi G, Pistillo C, Popov B, Porwit K, Posiadala-Zezula M, Prabhu YS, Pupilli F, Quilain B, Radermacher T, Radicioni E, Radics B, Ramírez MA, Ratoff PN, Reh M, Riccio C, Rondio E, Roth S, Roy N, Rubbia A, Ruggeri AC, Ruggles CA, Rychter A, Sakashita K, Sánchez F, Santucci G, Schloesser CM, Scholberg K, Scott M, Seiya Y, Sekiguchi T, Sekiya H, Sgalaberna D, Shaikhiev A, Shaker F, Shaykina A, Shiozawa M, Shorrock W, Shvartsman A, Skrobova N, Skwarczynski K, Smyczek D, Smy M, Sobczyk JT, Sobel H, Soler FJP, Sonoda Y, Speers AJ, Spina R, Suslov IA, Suvorov S, Suzuki A, Suzuki SY, Suzuki Y, Sztuc AA, Tada M, Tairafune S, Takayasu S, Takeda A, Takeuchi Y, Takifuji K, Tanaka HK, Tanihara Y, Tani M, Teklu A, Tereshchenko VV, Teshima N, Thamm N, Thompson LF, Toki W, Touramanis C, Towstego T, Tsui KM, Tsukamoto T, Tzanov M, Uchida Y, Vagins M, Vargas D, Varghese M, Vasseur G, Vilela C, Villa E, Vinning WGS, Virginet U, Vladisavljevic T, Wachala T, Walsh JG, Wang Y, Wan L, Wark D, Wascko MO, Weber A, Wendell R, Wilking MJ, Wilkinson C, Wilson JR, Wood K, Wret C, Xia J, Xu YH, Yamamoto K, Yamamoto T, Yanagisawa C, Yang G, Yano T, Yasutome K, Yershov N, Yevarouskaya U, Yokoyama M, Yoshimoto Y, Yoshimura N, Yu M, Zaki R, Zalewska A, Zalipska J, Zaremba K, Zarnecki G, Zhao X, Zhu T, Ziembicki M, Zimmerman ED, Zito M, Zsoldos S,\n\nThe European physical journal. C, Particles and fields.. 2023 83 (9):782. Epub 09/05/2023.\n\nDietary flavonoid carvacrol triggers the apoptosis of human breast cancer MCF-7 cells via the p53/Bax/Bcl-2 axis.\n\nMoradipour A, Dariushnejad H, Ahmadizadeh C, Lashgarian HE\n\nMedical oncology.. 2022 December 1040 (1):46. Epub 12/10/2022.\n\nSynthesize of BiO/Gln-TSC nanoparticles and evaluation of their toxicity on prostate cancer cells and expression of CASP8, BAX, and Bcl-2 genes.\n\nMoradi A, Abdihaji M, Kouchaksaraie SB, Alkinani TA, Mahmoudi A, Davoudi A, Dashtmiani W, Ghezeljeh SM, Aghajani S, Ghasemian R, Taramsari SM, Majlesi A, Niyaki ZM, Salehzadeh A\n\nScientific reports.. 2022 December 812 (1):21245. Epub 12/08/2022.\n\nGenomic Immune Evasion: Diagnostic and Therapeutic Opportunities in Head and Neck Squamous Cell Carcinomas.\n\nKirtane K, St John M, Fuentes-Bayne H, Patel SP, Mardiros A, Xu H, Ng EW, Go WY, Wong DJ, Sunwoo JB, Welch JS\n\nJournal of clinical medicine.. 2022 December 711 (24)Epub 12/07/2022.\n\nHadh deficiency induced oligoasthenoteratozoospermia through the TNF-?/Bcl-2 pathway in male mice.\n\nZhu H, Wang H, Cheng Y, Liu D, Zhang A, Wen Z, Gao J\n\nFASEB journal : official publication of the Federation of American Societies for Experimental Biology.. 2022 December 36 (12):e22661. Epub 1900 01 01.\n\nGenetic diversity fuels gene discovery for tobacco and alcohol use.\n\nSaunders GRB, Wang X, Chen F, Jang SK, Liu M, Wang C, Gao S, Jiang Y, Khunsriraksakul C, Otto JM, Addison C, Akiyama M, Albert CM, Aliev F, Alonso A, Arnett DK, Ashley-Koch AE, Ashrani AA, Barnes KC, Barr RG, Bartz TM, Becker DM, Bielak LF, Benjamin EJ, Bis JC, Bjornsdottir G, Blangero J, Bleecker ER, Boardman JD, Boerwinkle E, Boomsma DI, Boorgula MP, Bowden DW, Brody JA, Cade BE, Chasman DI, Chavan S, Chen YI, Chen Z, Cheng I, Cho MH, Choquet H, Cole JW, Cornelis MC, Cucca F, Curran JE, de Andrade M, Dick DM, Docherty AR, Duggirala R, Eaton CB, Ehringer MA, Esko T, Faul JD, Silva LF, Fiorillo E, Fornage M, Freedman BI, Gabrielsen ME, Garrett ME, Gharib SA, Gieger C, Gillespie N, Glahn DC, Gordon SD, Gu CC, Gu D, Gudbjartsson DF, Guo X, Haessler J, Hall ME, Haller T, Harris KM, He J, Herd P, Hewitt JK, Hickie I, Hidalgo B, Hokanson JE, Hopfer C, Hottenga J, Hou L, Huang H, Hung YJ, Hunter DJ, Hveem K, Hwang SJ, Hwu CM, Iacono W, Irvin MR, Jee YH, Johnson EO, Joo YY, Jorgenson E, Justice AE, Kamatani Y, Kaplan RC, Kaprio J, Kardia SLR, Keller MC, Kelly TN, Kooperberg C, Korhonen T, Kraft P, Krauter K, Kuusisto J, Laakso M, Lasky-Su J, Lee WJ, Lee JJ, Levy D, Li L, Li K, Li Y, Lin K, Lind PA, Liu C, Lloyd-Jones DM, Lutz SM, Ma J, Mägi R, Manichaikul A, Martin NG, Mathur R, Matoba N, McArdle PF, McGue M, McQueen MB, Medland SE, Metspalu A, Meyers DA, Millwood IY, Mitchell BD, Mohlke KL, Moll M, Montasser ME, Morrison AC, Mulas A, Nielsen JB, North KE, Oelsner EC, Okada Y, Orrù V, Palmer ND, Palviainen T, Pandit A, Park SL, Peters U, Peters A, Peyser PA, Polderman TJC, Rafaels N, Redline S, Reed RM, Reiner AP, Rice JP, Rich SS, Richmond NE, Roan C, Rotter JI, Rueschman MN, Runarsdottir V, Saccone NL, Schwartz DA, Shadyab AH, Shi J, Shringarpure SS, Sicinski K, Skogholt AH, Smith JA, Smith NL, Sotoodehnia N, Stallings MC, Stefansson H, Stefansson K, Stitzel JA, Sun X, Syed M, Tal-Singer R, Taylor AE, Taylor KD, Telen MJ, Thai KK, Tiwari H, Turman C, Tyrfingsson T, Wall TL, Walters RG, Weir DR, Weiss ST, White WB, Whitfield JB, Wiggins KL, Willemsen G, Willer CJ, Winsvold BS, Xu H, Yanek LR, Yin J, Young KL, Young KA, Yu B, Zhao W, Zhou W, Zöllner S, Zuccolo L, , , Batini C, Bergen AW, Bierut LJ, David SP, Gagliano Taliun SA, Hancock DB, Jiang B, Munafò MR, Thorgeirsson TE, Liu DJ, Vrieze S\n\nNature.. 2022 December 612 (7941):720-724. Epub 12/07/2022.\n\nEffective Tumor Debulking with Ibrutinib Before Initiation of Venetoclax: Results from the CAPTIVATE Minimal Residual Disease and Fixed-Duration Cohorts.\n\nBarr PM, Tedeschi A, Wierda WG, Allan JN, Ghia P, Vallisa D, Jacobs R, O'Brien S, Grigg AP, Walker P, Zhou C, Ninomoto J, Krigsfeld G, Tam CS\n\nClinical cancer research : an official journal of the American Association for Cancer Research.. 2022 October 1428 (20):4385-4391. Epub 1900 01 01.\n\nHuman herpesvirus 8-negative effusion-based large B-cell lymphoma: a distinct entity with unique clinicopathologic characteristics.\n\nGisriel SD, Yuan J, Braunberger RC, Maracaja DLV, Chen X, Wu X, McCracken J, Chen M, Xie Y, Brown LE, Li P, Zhou Y, Sethi T, McHenry A, Hauser RG, Paulson N, Tang H, Hsi ED, Wang E, Zhang QY, Young KH, Xu ML, Pan Z\n\nModern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.. 2022 October 35 (10):1411-1422. Epub 05/13/2022.\n\nCLL-418 Characteristics and Clinical Outcomes of Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Receiving Long-Term Ibrutinib Treatment in the RESONATE-2 Study.\n\nWoyach JA, Barr PM, Kipps TJ, Barrientos JC, Ahn IE, Ghia P, Girardi V, Hsu E, Jermain M, Burger JA\n\nClinical lymphoma, myeloma & leukemia.. 2022 October 22 Suppl 2 :S278. Epub 1900 01 01.\n\neQTL Set-Based Association Analysis Identifies Novel Susceptibility Loci for Barrett Esophagus and Esophageal Adenocarcinoma.\n\nWang X, Gharahkhani P, Levine DM, Fitzgerald RC, Gockel I, Corley DA, Risch HA, Bernstein L, Chow WH, Onstad L, Shaheen NJ, Lagergren J, Hardie LJ, Wu AH, Pharoah PDP, Liu G, Anderson LA, Iyer PG, Gammon MD, Caldas C, Ye W, Barr H, Moayyedi P, Harrison R, Watson RP, Attwood S, Chegwidden L, Love SB, MacDonald D, deCaestecker J, Prenen H, Ott K, Moebus S, Venerito M, Lang H, Mayershofer R, Knapp M, Veits L, Gerges C, Weissmüller J, Reeh M, Nöthen MM, Izbicki JR, Manner H, Neuhaus H, Rösch T, Böhmer AC, Hölscher AH, Anders M, Pech O, Schumacher B, Schmidt C, Schmidt T, Noder T, Lorenz D, Vieth M, May A, Hess T, Kreuser N, Becker J, Ell C, Tomlinson I, Palles C, Jankowski JA, Whiteman DC, MacGregor S, Schumacher J, Vaughan TL, Buas MF, Dai JY\n\nCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.. 2022 September 231 (9):1735-1745. Epub 1900 01 01.\n\nPolymorphic variants of the CASP3, CASP9, BCL-2 and NKX3-1 genes as candidate markers for prostate cancer susceptibility and poor prognosis.\n\nde Souza MR, de Souza MF, de Nóbrega M, Cilião HL, Dos Reis MB, Fuganti PE, Cólus IMS\n\nMolecular biology reports.. 2022 September 49 (9):9079-9087. Epub 06/16/2022.\n\nMicroplastics and di (2-ethylhexyl) phthalate synergistically induce apoptosis in mouse pancreas through the GRP78/CHOP/Bcl-2 pathway activated by oxidative stress.\n\nWang Y, Zhang Y, Sun X, Shi X, Xu S\n\nFood and chemical toxicology : an international journal published for the British Industrial Biological Research Association.. 2022 September 167 :113315. Epub 07/19/2022.\n\nVenetoclax retreatment of patients with chronic lymphocytic leukemia after a previous venetoclax-based regimen.\n\nThompson MC, Harrup RA, Coombs CC, Roeker LE, Pu JJ, Choi MY, Barr PM, Allan JN, Šimkovi? M, Leslie LA, Rhodes J, Chong EA, Kamdar M, Skarbnik AP, Lansigan F, McCall BJ, Saja K, Dyer MJS, Walter HS, Lefebure M, Thadani-Mulero M, Boyer M, Biondo JML, Sail K, Manzoor BS, Furman RR, Bantilan KS, Goy A, Feldman T, Labella D, Schuster SJ, Park JH, Palomba ML, Zelenetz AD, Eyre TA, Kater AP, Seymour JF, Mato AR\n\nBlood advances.. 2022 August 96 (15):4553-4557. Epub 1900 01 01.\n\nSearch for Subsolar-Mass Binaries in the First Half of Advanced LIGO's and Advanced Virgo's Third Observing Run.\n\nAbbott R, Abbott TD, Acernese F, Ackley K, Adams C, Adhikari N, Adhikari RX, Adya VB, Affeldt C, Agarwal D, Agathos M, Agatsuma K, Aggarwal N, Aguiar OD, Aiello L, Ain A, Ajith P, Albanesi S, Allocca A, Altin PA, Amato A, Anand C, Anand S, Ananyeva A, Anderson SB, Anderson WG, Andrade T, Andres N, Andri? T, Angelova SV, Ansoldi S, Antelis JM, Antier S, Appert S, Arai K, Araya MC, Areeda JS, Arène M, Arnaud N, Aronson SM, Arun KG, Asali Y, Ashton G, Assiduo M, Aston SM, Astone P, Aubin F, Austin C, Babak S, Badaracco F, Bader MKM, Badger C, Bae S, Baer AM, Bagnasco S, Bai Y, Baird J, Ball M, Ballardin G, Ballmer SW, Balsamo A, Baltus G, Banagiri S, Bankar D, Barayoga JC, Barbieri C, Barish BC, Barker D, Barneo P, Barone F, Barr B, Barsotti L, Barsuglia M, Barta D, Bartlett J, Barton MA, Bartos I, Bassiri R, Basti A, Bawaj M, Bayley JC, Baylor AC, Bazzan M, Bécsy B, Bedakihale VM, Bejger M, Belahcene I, Benedetto V, Beniwal D, Bennett TF, Bentley JD, BenYaala M, Bergamin F, Berger BK, Bernuzzi S, Berry CPL, Bersanetti D, Bertolini A, Betzwieser J, Beveridge D, Bhandare R, Bhardwaj U, Bhattacharjee D, Bhaumik S, Bilenko IA, Billingsley G, Bini S, Birney R, Birnholtz O, Biscans S, Bischi M, Biscoveanu S, Bisht A, Biswas B, Bitossi M, Bizouard MA, Blackburn JK, Blair CD, Blair DG, Blair RM, Bobba F, Bode N, Boer M, Bogaert G, Boldrini M, Bonavena LD, Bondu F, Bonilla E, Bonnand R, Booker P, Boom BA, Bork R, Boschi V, Bose N, Bose S, Bossilkov V, Boudart V, Bouffanais Y, Bozzi A, Bradaschia C, Brady PR, Bramley A, Branch A, Branchesi M, Brau JE, Breschi M, Briant T, Briggs JH, Brillet A, Brinkmann M, Brockill P, Brooks AF, Brooks J, Brown DD, Brunett S, Bruno G, Bruntz R, Bryant J, Bulik T, Bulten HJ, Buonanno A, Buscicchio R, Buskulic D, Buy C, Byer RL, Cadonati L, Cagnoli G, Cahillane C, Bustillo JC, Callaghan JD, Callister TA, Calloni E, Cameron J, Camp JB, Canepa M, Canevarolo S, Cannavacciuolo M, Cannon KC, Cao H, Capote E, Carapella G, Carbognani F, Carlin JB, Carney MF, Carpinelli M, Carrillo G, Carullo G, Carver TL, Diaz JC, Casentini C, Castaldi G, Caudill S, Cavaglià M, Cavalier F, Cavalieri R, Ceasar M, Cella G, Cerdá-Durán P, Cesarini E, Chaibi W, Chakravarti K, Subrahmanya SC, Champion E, Chan CH, Chan C, Chan CL, Chan K, Chandra K, Chanial P, Chao S, Charlton P, Chase EA, Chassande-Mottin E, Chatterjee C, Chatterjee D, Chatterjee D, Chaturvedi M, Chaty S, Chatziioannou K, Chen HY, Chen J, Chen X, Chen Y, Chen Z, Cheng H, Cheong CK, Cheung HY, Chia HY, Chiadini F, Chiarini G, Chierici R, Chincarini A, Chiofalo ML, Chiummo A, Cho G, Cho HS, Choudhary RK, Choudhary S, Christensen N, Chu Q, Chua S, Chung KW, Ciani G, Ciecielag P, Cie?lar M, Cifaldi M, Ciobanu AA, Ciolfi R, Cipriano F, Cirone A, Clara F, Clark EN, Clark JA, Clarke L, Clearwater P, Clesse S, Cleva F, Coccia E, Codazzo E, Cohadon PF, Cohen DE, Cohen L, Colleoni M, Collette CG, Colombo A, Colpi M, Compton CM, Constancio M, Conti L, Cooper SJ, Corban P, Corbitt TR, Cordero-Carrión I, Corezzi S, Corley KR, Cornish N, Corre D, Corsi A, Cortese S, Costa CA, Cotesta R, Coughlin MW, Coulon JP, Countryman ST, Cousins B, Couvares P, Coward DM, Cowart MJ, Coyne DC, Coyne R, Creighton JDE, Creighton TD, Criswell AW, Croquette M, Crowder SG, Cudell JR, Cullen TJ, Cumming A, Cummings R, Cunningham L, Cuoco E, Cury?o M, Dabadie P, Canton TD, Dall'Osso S, Dálya G, Dana A, DaneshgaranBajastani LM, D'Angelo B, Danilishin S, D'Antonio S, Danzmann K, Darsow-Fromm C, Dasgupta A, Datrier LEH, Datta S, Dattilo V, Dave I, Davier M, Davies GS, Davis D, Davis MC, Daw EJ, Dean R, DeBra D, Deenadayalan M, Degallaix J, De Laurentis M, Deléglise S, Del Favero V, De Lillo F, De Lillo N, Del Pozzo W, DeMarchi LM, De Matteis F, D'Emilio V, Demos N, Dent T, Depasse A, De Pietri R, De Rosa R, De Rossi C, DeSalvo R, De Simone R, Dhurandhar S, Díaz MC, Diaz-Ortiz M, Didio NA, Dietrich T, Di Fiore L, Di Fronzo C, Di Giorgio C, Di Giovanni F, Di Giovanni M, Di Girolamo T, Di Lieto A, Ding B, Di Pace S, Di Palma I, Di Renzo F, Divakarla AK, Dmitriev A, Doctor Z, D'Onofrio L, Donovan F, Dooley KL, Doravari S, Dorrington I, Drago M, Driggers JC, Drori Y, Ducoin JG, Dupej P, Durante O, D'Urso D, Duverne PA, Dwyer SE, Eassa C, Easter PJ, Ebersold M, Eckhardt T, Eddolls G, Edelman B, Edo TB, Edy O, Effler A, Eichholz J, Eikenberry SS, Eisenmann M, Eisenstein RA, Ejlli A, Engelby E, Errico L, Essick RC, Estellés H, Estevez D, Etienne Z, Etzel T, Evans M, Evans TM, Ewing BE, Fafone V, Fair H, Fairhurst S, Farah AM, Farinon S, Farr B, Farr WM, Farrow NW, Fauchon-Jones EJ, Favaro G, Favata M, Fays M, Fazio M, Feicht J, Fejer MM, Fekecs B, Fenyvesi E, Ferguson DL, Fernandez-Galiana A, Ferrante I, Ferreira TA, Fidecaro F, Figura P, Fiori I, Fishbach M, Fisher RP, Fittipaldi R, Fiumara V, Flaminio R, Floden E, Fong H, Font JA, Fornal B, Forsyth PWF, Franke A, Frasca S, Frasconi F, Frederick C, Freed JP, Frei Z, Freise A, Frey R, Fritschel P, Frolov VV, Fronzé GG, Fulda P, Fyffe M, Gabbard HA, Gadre BU, Gair JR, Gais J, Galaudage S, Gamba R, Ganapathy D, Ganguly A, Gaonkar SG, Garaventa B, García-Núñez C, García-Quirós C, Garufi F, Gateley B, Gaudio S, Gayathri V, Gemme G, Gennai A, George J, Gerberding O, Gergely L, Gewecke P, Ghonge S, Ghosh A, Ghosh A, Ghosh S, Ghosh S, Giacomazzo B, Giacoppo L, Giaime JA, Giardina KD, Gibson DR, Gier C, Giesler M, Giri P, Gissi F, Glanzer J, Gleckl AE, Godwin P, Goetz E, Goetz R, Gohlke N, Goncharov B, González G, Gopakumar A, Gosselin M, Gouaty R, Gould DW, Grace B, Grado A, Granata M, Granata V, Grant A, Gras S, Grassia P, Gray C, Gray R, Greco G, Green AC, Green R, Gretarsson AM, Gretarsson EM, Griffith D, Griffiths W, Griggs HL, Grignani G, Grimaldi A, Grimm SJ, Grote H, Grunewald S, Gruning P, Guerra D, Guidi GM, Guimaraes AR, Guixé G, Gulati HK, Guo HK, Guo Y, Gupta A, Gupta A, Gupta P, Gustafson EK, Gustafson R, Guzman F, Haegel L, Halim O, Hall ED, Hamilton EZ, Hammond G, Haney M, Hanks J, Hanna C, Hannam MD, Hannuksela O, Hansen H, Hansen TJ, Hanson J, Harder T, Hardwick T, Haris K, Harms J, Harry GM, Harry IW, Hartwig D, Haskell B, Hasskew RK, Haster CJ, Haughian K, Hayes FJ, Healy J, Heidmann A, Heidt A, Heintze MC, Heinze J, Heinzel J, Heitmann H, Hellman F, Hello P, Helmling-Cornell AF, Hemming G, Hendry M, Heng IS, Hennes E, Hennig J, Hennig MH, Hernandez AG, Vivanco FH, Heurs M, Hild S, Hill P, Hines AS, Hochheim S, Hofman D, Hohmann JN, Holcomb DG, Holland NA, Hollows IJ, Holmes ZJ, Holt K, Holz DE, Hopkins P, Hough J, Hourihane S, Howell EJ, Hoy CG, Hoyland D, Hreibi A, Hsu Y, Huang Y, Hübner MT, Huddart AD, Hughey B, Hui V, Husa S, Huttner SH, Huxford R, Huynh-Dinh T, Idzkowski B, Iess A, Ingram C, Isi M, Isleif K, Iyer BR, JaberianHamedan V, Jacqmin T, Jadhav SJ, Jadhav SP, James AL, Jan AZ, Jani K, Janquart J, Janssens K, Janthalur NN, Jaranowski P, Jariwala D, Jaume R, Jenkins AC, Jenner K, Jeunon M, Jia W, Johns GR, Jones AW, Jones DI, Jones JD, Jones P, Jones R, Jonker RJG, Ju L, Junker J, Juste V, Kalaghatgi CV, Kalogera V, Kamai B, Kandhasamy S, Kang G, Kanner JB, Kao Y, Kapadia SJ, Kapasi DP, Karat S, Karathanasis C, Karki S, Kashyap R, Kasprzack M, Kastaun W, Katsanevas S, Katsavounidis E, Katzman W, Kaur T, Kawabe K, Kéfélian F, Keitel D, Key JS, Khadka S, Khalili FY, Khan S, Khazanov EA, Khetan N, Khursheed M, Kijbunchoo N, Kim C, Kim JC, Kim K, Kim WS, Kim YM, Kimball C, Kinley-Hanlon M, Kirchhoff R, Kissel JS, Kleybolte L, Klimenko S, Knee AM, Knowles TD, Knyazev E, Koch P, Koekoek G, Koley S, Kolitsidou P, Kolstein M, Komori K, Kondrashov V, Kontos A, Koper N, Korobko M, Kovalam M, Kozak DB, Kringel V, Krishnendu NV, Królak A, Kuehn G, Kuei F, Kuijer P, Kumar A, Kumar P, Kumar R, Kumar R, Kuns K, Kuwahara S, Lagabbe P, Laghi D, Lalande E, Lam TL, Lamberts A, Landry M, Lane BB, Lang RN, Lange J, Lantz B, La Rosa I, Lartaux-Vollard A, Lasky PD, Laxen M, Lazzarini A, Lazzaro C, Leaci P, Leavey S, Lecoeuche YK, Lee HM, Lee HW, Lee J, Lee K, Lehmann J, Lemaître A, Leroy N, Letendre N, Levesque C, Levin Y, Leviton JN, Leyde K, Li AKY, Li B, Li J, Li TGF, Li X, Linde F, Linker SD, Linley JN, Littenberg TB, Liu J, Liu K, Liu X, Llamas F, Llorens-Monteagudo M, Lo RKL, Lockwood A, London LT, Longo A, Lopez D, Portilla ML, Lorenzini M, Loriette V, Lormand M, Losurdo G, Lott TP, Lough JD, Lousto CO, Lovelace G, Lucaccioni JF, Lück H, Lumaca D, Lundgren AP, Lynam JE, Macas R, MacInnis M, Macleod DM, MacMillan IAO, Macquet A, Hernandez IM, Magazzù C, Magee RM, Maggiore R, Magnozzi M, Mahesh S, Majorana E, Makarem C, Maksimovic I, Maliakal S, Malik A, Man N, Mandic V, Mangano V, Mango JL, Mansell GL, Manske M, Mantovani M, Mapelli M, Marchesoni F, Marion F, Mark Z, Márka S, Márka Z, Markakis C, Markosyan AS, Markowitz A, Maros E, Marquina A, Marsat S, Martelli F, Martin IW, Martin RM, Martinez M, Martinez VA, Martinez V, Martinovic K, Martynov DV, Marx EJ, Masalehdan H, Mason K, Massera E, Masserot A, Massinger TJ, Masso-Reid M, Mastrogiovanni S, Matas A, Mateu-Lucena M, Matichard F, Matiushechkina M, Mavalvala N, McCann JJ, McCarthy R, McClelland DE, McClincy PK, McCormick S, McCuller L, McGhee GI, McGuire SC, McIsaac C, McIver J, McRae T, McWilliams ST, Meacher D, Mehmet M, Mehta AK, Meijer Q, Melatos A, Melchor DA, Mendell G, Menendez-Vazquez A, Menoni CS, Mercer RA, Mereni L, Merfeld K, Merilh EL, Merritt JD, Merzougui M, Meshkov S, Messenger C, Messick C, Meyers PM, Meylahn F, Mhaske A, Miani A, Miao H, Michaloliakos I, Michel C, Middleton H, Milano L, Miller A, Miller AL, Miller B, Millhouse M, Mills JC, Milotti E, Minazzoli O, Minenkov Y, Mir LM, Miravet-Tenés M, Mishra C, Mishra T, Mistry T, Mitra S, Mitrofanov VP, Mitselmakher G, Mittleman R, Mo G, Moguel E, Mogushi K, Mohapatra SRP, Mohite SR, Molina I, Molina-Ruiz M, Mondin M, Montani M, Moore CJ, Moraru D, Morawski F, More A, Moreno C, Moreno G, Morisaki S, Mours B, Mow-Lowry CM, Mozzon S, Muciaccia F, Mukherjee A, Mukherjee D, Mukherjee S, Mukherjee S, Mukherjee S, Mukund N, Mullavey A, Munch J, Muñiz EA, Murray PG, Musenich R, Muusse S, Nadji SL, Nagar A, Napolano V, Nardecchia I, Naticchioni L, Nayak B, Nayak RK, Neil BF, Neilson J, Nelemans G, Nelson TJN, Nery M, Neubauer P, Neunzert A, Ng KY, Ng SWS, Nguyen C, Nguyen P, Nguyen T, Nichols SA, Nissanke S, Nitoglia E, Nocera F, Norman M, North C, Nuttall LK, Oberling J, O'Brien BD, O'Dell J, Oelker E, Oganesyan G, Oh JJ, Oh SH, Ohme F, Ohta H, Okada MA, Olivetto C, Oram R, O'Reilly B, Ormiston RG, Ormsby ND, Ortega LF, O'Shaughnessy R, O'Shea E, Ossokine S, Osthelder C, Ottaway DJ, Overmier H, Pace AE, Pagano G, Page MA, Pagliaroli G, Pai A, Pai SA, Palamos JR, Palashov O, Palomba C, Pan H, Panda PK, Pang PTH, Pankow C, Pannarale F, Pant BC, Panther FH, Paoletti F, Paoli A, Paolone A, Park H, Parker W, Pascucci D, Pasqualetti A, Passaquieti R, Passuello D, Patel M, Pathak M, Patricelli B, Patron AS, Paul S, Payne E, Pedraza M, Pegoraro M, Pele A, Penn S, Perego A, Pereira A, Pereira T, Perez CJ, Périgois C, Perkins CC, Perreca A, Perriès S, Petermann J, Petterson D, Pfeiffer HP, Pham KA, Phukon KS, Piccinni OJ, Pichot M, Piendibene M, Piergiovanni F, Pierini L, Pierro V, Pillant G, Pillas M, Pilo F, Pinard L, Pinto IM, Pinto M, Piotrzkowski K, Pirello M, Pitkin MD, Placidi E, Planas L, Plastino W, Pluchar C, Poggiani R, Polini E, Pong DYT, Ponrathnam S, Popolizio P, Porter EK, Poulton R, Powell J, Pracchia M, Pradier T, Prajapati AK, Prasai K, Prasanna R, Pratten G, Principe M, Prodi GA, Prokhorov L, Prosposito P, Prudenzi L, Puecher A, Punturo M, Puosi F, Puppo P, Pürrer M, Qi H, Quetschke V, Quitzow-James R, Raab FJ, Raaijmakers G, Radkins H, Radulesco N, Raffai P, Rail SX, Raja S, Rajan C, Ramirez KE, Ramirez TD, Ramos-Buades A, Rana J, Rapagnani P, Rapol UD, Ray A, Raymond V, Raza N, Razzano M, Read J, Rees LA, Regimbau T, Rei L, Reid S, Reid SW, Reitze DH, Relton P, Renzini A, Rettegno P, Rezac M, Ricci F, Richards D, Richardson JW, Richardson L, Riemenschneider G, Riles K, Rinaldi S, Rink K, Rizzo M, Robertson NA, Robie R, Robinet F, Rocchi A, Rodriguez S, Rolland L, Rollins JG, Romanelli M, Romano R, Romel CL, Romero-Rodríguez A, Romero-Shaw IM, Romie JH, Ronchini S, Rosa L, Rose CA, Rosi?ska D, Ross MP, Rowan S, Rowlinson SJ, Roy S, Roy S, Roy S, Rozza D, Ruggi P, Ryan K, Sachdev S, Sadecki T, Sadiq J, Sakellariadou M, Salafia OS, Salconi L, Saleem M, Salemi F, Samajdar A, Sanchez EJ, Sanchez JH, Sanchez LE, Sanchis-Gual N, Sanders JR, Sanuy A, Saravanan TR, Sarin N, Sassolas B, Satari H, Sathyaprakash BS, Sauter O, Savage RL, Sawant D, Sawant HL, Sayah S, Schaetzl D, Scheel M, Scheuer J, Schiworski M, Schmidt P, Schmidt S, Schnabel R, Schneewind M, Schofield RMS, Schönbeck A, Schulte BW, Schutz BF, Schwartz E, Scott J, Scott SM, Seglar-Arroyo M, Sellers D, Sengupta AS, Sentenac D, Seo EG, Sequino V, Sergeev A, Setyawati Y, Shaffer T, Shahriar MS, Shams B, Sharma A, Sharma P, Shawhan P, Shcheblanov NS, Shikauchi M, Shoemaker DH, Shoemaker DM, ShyamSundar S, Sieniawska M, Sigg D, Singer LP, Singh D, Singh N, Singha A, Sintes AM, Sipala V, Skliris V, Slagmolen BJJ, Slaven-Blair TJ, Smetana J, Smith JR, Smith RJE, Soldateschi J, Somala SN, Son EJ, Soni K, Soni S, Sordini V, Sorrentino F, Sorrentino N, Soulard R, Souradeep T, Sowell E, Spagnuolo V, Spencer AP, Spera M, Srinivasan R, Srivastava AK, Srivastava V, Staats K, Stachie C, Steer DA, Steinlechner J, Steinlechner S, Stevenson S, Stops DJ, Stover M, Strain KA, Strang LC, Stratta G, Strunk A, Sturani R, Stuver AL, Sudhagar S, Sudhir V, Suh HG, Summerscales TZ, Sun H, Sun L, Sunil S, Sur A, Suresh J, Sutton PJ, Swinkels BL, Szczepa?czyk MJ, Szewczyk P, Tacca M, Tait SC, Talbot CJ, Talbot C, Tanasijczuk AJ, Tanner DB, Tao D, Tao L, Martín ENTS, Taranto C, Tasson JD, Tenorio R, Terhune JE, Terkowski L, Thirugnanasambandam MP, Thomas M, Thomas P, Thompson JE, Thondapu SR, Thorne KA, Thrane E, Tiwari S, Tiwari S, Tiwari V, Toivonen AM, Toland K, Tolley AE, Tonelli M, Torres-Forné A, Torrie CI, E Melo IT, Töyrä D, Trapananti A, Travasso F, Traylor G, Trevor M, Tringali MC, Tripathee A, Troiano L, Trovato A, Trozzo L, Trudeau RJ, Tsai DS, Tsai D, Tsang KW, Tse M, Tso R, Tsukada L, Tsuna D, Tsutsui T, Turbang K, Turconi M, Ubhi AS, Udall RP, Ueno K, Unnikrishnan CS, Urban AL, Utina A, Vahlbruch H, Vajente G, Vajpeyi A, Valdes G, Valentini M, Valsan V, van Bakel N, van Beuzekom M, van den Brand JFJ, Van Den Broeck C, Vander-Hyde DC, van der Schaaf L, van Heijningen JV, Vanosky J, van Remortel N, Vardaro M, Vargas AF, Varma V, Vasúth M, Vecchio A, Vedovato G, Veitch J, Veitch PJ, Venneberg J, Venugopalan G, Verkindt D, Verma P, Verma Y, Veske D, Vetrano F, Viceré A, Vidyant S, Viets AD, Vijaykumar A, Villa-Ortega V, Vinet JY, Virtuoso A, Vitale S, Vo T, Vocca H, von Reis ERG, von Wrangel JSA, Vorvick C, Vyatchanin SP, Wade LE, Wade M, Wagner KJ, Walet RC, Walker M, Wallace GS, Wallace L, Walsh S, Wang JZ, Wang WH, Ward RL, Warner J, Was M, Washington NY, Watchi J, Weaver B, Webster SA, Weinert M, Weinstein AJ, Weiss R, Weller CM, Wellmann F, Wen L, Weßels P, Wette K, Whelan JT, White DD, Whiting BF, Whittle C, Wilken D, Williams D, Williams MJ, Williamson AR, Willis JL, Willke B, Wilson DJ, Winkler W, Wipf CC, Wlodarczyk T, Woan G, Woehler J, Wofford JK, Wong ICF, Wu DS, Wysocki DM, Xiao L, Yamamoto H, Yang FW, Yang L, Yang Y, Yang Z, Yap MJ, Yeeles DW, Yelikar AB, Ying M, Yoo J, Yu H, Yu H, Zadro?ny A, Zanolin M, Zelenova T, Zendri JP, Zevin M, Zhang J, Zhang L, Zhang T, Zhang Y, Zhao C, Zhao G, Zhao Y, Zhou R, Zhou Z, Zhu XJ, Zimmerman AB, Zucker ME, Zweizig J, Jeong D, Shandera S,\n\nPhysical review letters.. 2022 August 5129 (6):061104. Epub 1900 01 01.\n\nLong-term outcomes for ibrutinib-rituximab and chemoimmunotherapy in CLL: updated results of the E1912 trial.\n\nShanafelt TD, Wang XV, Hanson CA, Paietta EM, O'Brien S, Barrientos JC, Jelinek DF, Braggio E, Leis JF, Zhang CC, Coutre SE, Barr PM, Cashen AF, Mato AR, Singh AK, Mullane MP, Little RF, Erba HP, Stone RM, Litzow MR, Tallman MS, Kay NE\n\nBlood.. 2022 July 14140 (2):112-120. Epub 1900 01 01.\n\nPhase 1/2 study of acalabrutinib and the PI3K delta inhibitor ACP-319 in relapsed/refractory B-cell Non-Hodgkin lymphoma.\n\nBarr PM, Smith S, Roschewski M, O'Brien SM, Sharman JP, Melear JM, Patel P, Calvo R, Yang H, Spurgeon S\n\nLeukemia & lymphoma.. 2022 July 63 (7):1728-1732. Epub 02/24/2022.\n\nCharacterization of low-grade arthralgia, myalgia, and musculoskeletal pain with ibrutinib therapy: pooled analysis of clinical trials in patients with chronic lymphocytic leukemia and mantle cell lymphoma.\n\nSiddiqi T, Coutre S, McKinney M, Barr PM, Rogers K, Mokatrin A, Valentino R, Szoke A, Deshpande S, Zhu A, Arango-Hisijara I, Osei-Bonsu K, Wang M, O'Brien S\n\nLeukemia & lymphoma.. 2022 July 63 (7):1580-1588. Epub 02/28/2022.\n\nAberrant expression of lymphoid enhancer-binding factor 1 in Hodgkin lymphoma.\n\nRavindran A, Kurtin PJ, King RL, Yuan J, Feldman AL, Rech KL, McPhail ED, Parikh SA, Ding W, Shi M\n\nHuman pathology.. 2022 July 125 :2-10. Epub 04/12/2022.\n\nHyperactivity of the CD155 immune checkpoint suppresses anti-viral immunity in patients with coronary artery disease.\n\nZhao TV, Hu Z, Ohtsuki S, Jin K, Wu B, Berry GJ, Frye RL, Goronzy JJ, Weyand CM\n\nNature cardiovascular research.. 2022 July 1 (7):634-648. Epub 07/13/2022.\n\nSearch for an Excess of Electron Neutrino Interactions in MicroBooNE Using Multiple Final-State Topologies.\n\nAbratenko P, An R, Anthony J, Arellano L, Asaadi J, Ashkenazi A, Balasubramanian S, Baller B, Barnes C, Barr G, Basque V, Bathe-Peters L, Benevides Rodrigues O, Berkman S, Bhanderi A, Bhat A, Bishai M, Blake A, Bolton T, Book JY, Camilleri L, Caratelli D, Caro Terrazas I, Cavanna F, Cerati G, Chen Y, Cianci D, Collin GH, Conrad JM, Convery M, Cooper-Troendle L, Crespo-Anadón JI, Del Tutto M, Dennis SR, Detje P, Devitt A, Diurba R, Dorrill R, Duffy K, Dytman S, Eberly B, Ereditato A, Escudero Sanchez L, Evans JJ, Fine R, Fiorentini Aguirre GA, Fitzpatrick RS, Fleming BT, Foppiani N, Franco D, Furmanski AP, Garcia-Gamez D, Gardiner S, Ge G, Genty V, Gollapinni S, Goodwin O, Gramellini E, Green P, Greenlee H, Gu W, Guenette R, Guzowski P, Hagaman L, Hen O, Hilgenberg C, Horton-Smith GA, Hourlier A, Itay R, James C, Ji X, Jiang L, Jo JH, Johnson RA, Jwa YJ, Kaleko D, Kalra D, Kamp N, Kaneshige N, Karagiorgi G, Ketchum W, Kirby M, Kobilarcik T, Kreslo I, LaZur R, Lepetic I, Li K, Li Y, Lin K, Lister A, Littlejohn BR, Louis WC, Luo X, Manivannan K, Mariani C, Marsden D, Marshall J, Martinez Caicedo DA, Mason K, Mastbaum A, McConkey N, Meddage V, Mettler T, Miller K, Mills J, Mistry K, Mogan A, Mohayai T, Moon J, Mooney M, Moor AF, Moore CD, Mora Lepin L, Mousseau J, Murphy M, Naples D, Navrer-Agasson A, Nebot-Guinot M, Neely RK, Newmark DA, Nowak J, Nunes M, Palamara O, Paolone V, Papadopoulou A, Papavassiliou V, Pate SF, Patel N, Paudel A, Pavlovic Z, Piasetzky E, Ponce-Pinto ID, Prince S, Qian X, Raaf JL, Radeka V, Rafique A, Reggiani-Guzzo M, Ren L, Rice LCJ, Rochester L, Rodriguez Rondon J, Rosenberg M, Ross-Lonergan M, Russell B, Scanavini G, Schmitz DW, Schukraft A, Seligman W, Shaevitz MH, Sharankova R, Shi J, Sinclair J, Smith A, Snider EL, Soderberg M, Söldner-Rembold S, Soleti SR, Spentzouris P, Spitz J, Stancari M, John JS, Strauss T, Sutton K, Sword-Fehlberg S, Szelc AM, Tang W, Terao K, Thomson M, Thorpe C, Totani D, Toups M, Tsai YT, Uchida MA, Usher T, Van De Pontseele W, Viren B, Weber M, Wei H, Williams Z, Wolbers S, Wongjirad T, Wospakrik M, Wresilo K, Wright N, Wu W, Yandel E, Yang T, Yarbrough G, Yates LE, Yu HW, Zeller GP, Zennamo J, Zhang C,\n\nPhysical review letters.. 2022 June 17128 (24):241801. Epub 1900 01 01.\n\nUp to 8-year follow-up from RESONATE-2: first-line ibrutinib treatment for patients with chronic lymphocytic leukemia.\n\nBarr PM, Owen C, Robak T, Tedeschi A, Bairey O, Burger JA, Hillmen P, Coutre SE, Dearden C, Grosicki S, McCarthy H, Li JY, Offner F, Moreno C, Zhou C, Hsu E, Szoke A, Kipps TJ, Ghia P\n\nBlood advances.. 2022 June 146 (11):3440-3450. Epub 1900 01 01.\n\nFixed-duration ibrutinib plus venetoclax for first-line treatment of CLL: primary analysis of the CAPTIVATE FD cohort.\n\nTam CS, Allan JN, Siddiqi T, Kipps TJ, Jacobs RW, Opat S, Barr PM, Tedeschi A, Trentin L, Bannerji R, Jackson SR, Kuss BJ, Moreno C, Szafer-Glusman E, Russell K, Zhou C, Ninomoto JS, Dean JP, Wierda WG, Ghia P\n\nBlood.. 2022 June 2139 (22):3278-3289. Epub 1900 01 01.\n\nThe immunogenetics of viral antigen response is associated with subtype-specific glioma risk and survival.\n\nGuerra G, Kachuri L, Wendt G, Hansen HM, Mack SJ, Molinaro AM, Rice T, Bracci P, Wiencke JK, Kasahara N, Eckel-Passow JE, Jenkins RB, Wrensch M, Francis SS\n\nAmerican journal of human genetics.. 2022 June 2109 (6):1105-1116. Epub 05/11/2022.\n\nThe highly selective Bruton tyrosine kinase inhibitor acalabrutinib leaves macrophage phagocytosis intact.\n\nPinney JJ, Blick-Nitko SK, Baran AM, Peterson DR, Whitehead HE, Izumi R, Munugalavadla V, Van DerMeid KR, Barr PM, Zent CS, Elliott MR, Chu CC\n\nHaematologica.. 2022 June 1107 (6):1460-1465. Epub 06/01/2022.\n\nDefining Novel DNA Virus-Tumor Associations and Genomic Correlates Using Prospective Clinical Tumor/Normal Matched Sequencing Data.\n\nVanderbilt CM, Bowman AS, Middha S, Petrova-Drus K, Tang YW, Chen X, Wang Y, Chang J, Rekhtman N, Busam KJ, Gupta S, Hameed M, Arcila ME, Ladanyi M, Berger MF, Dogan S, Zehir A\n\nThe Journal of molecular diagnostics : JMD.. 2022 May 24 (5):515-528. Epub 03/22/2022.\n\nA Case of Painless Subacute Thyroiditis Presenting as Fever of Unknown Origin.\n\nNeupane B, Karki S, Tirthani E, Jadhav N, Gupta N\n\nCure?us.. 2022 May 14 (5):e24949. Epub 05/12/2022.\n\nFirst Measurement of Energy-Dependent Inclusive Muon Neutrino Charged-Current Cross Sections on Argon with the MicroBooNE Detector.\n\nAbratenko P, An R, Anthony J, Arellano L, Asaadi J, Ashkenazi A, Balasubramanian S, Baller B, Barnes C, Barr G, Basque V, Bathe-Peters L, Benevides Rodrigues O, Berkman S, Bhanderi A, Bhat A, Bishai M, Blake A, Bolton T, Book JY, Camilleri L, Caratelli D, Caro Terrazas I, Cavanna F, Cerati G, Chen Y, Cianci D, Conrad JM, Convery M, Cooper-Troendle L, Crespo-Anadón JI, Del Tutto M, Dennis SR, Detje P, Devitt A, Diurba R, Dorrill R, Duffy K, Dytman S, Eberly B, Ereditato A, Evans JJ, Fine R, Fiorentini Aguirre GA, Fitzpatrick RS, Fleming BT, Foppiani N, Franco D, Furmanski AP, Garcia-Gamez D, Gardiner S, Ge G, Gollapinni S, Goodwin O, Gramellini E, Green P, Greenlee H, Gu W, Guenette R, Guzowski P, Hagaman L, Hen O, Hilgenberg C, Horton-Smith GA, Hourlier A, Itay R, James C, Ji X, Jiang L, Jo JH, Johnson RA, Jwa YJ, Kalra D, Kamp N, Kaneshige N, Karagiorgi G, Ketchum W, Kirby M, Kobilarcik T, Kreslo I, Lepetic I, Li K, Li Y, Lin K, Littlejohn BR, Louis WC, Luo X, Manivannan K, Mariani C, Marsden D, Marshall J, Martinez Caicedo DA, Mason K, Mastbaum A, McConkey N, Meddage V, Mettler T, Miller K, Mills J, Mistry K, Mogan A, Mohayai T, Moon J, Mooney M, Moor AF, Moore CD, Mora Lepin L, Mousseau J, Murphy M, Naples D, Navrer-Agasson A, Nebot-Guinot M, Neely RK, Newmark DA, Nowak J, Nunes M, Palamara O, Paolone V, Papadopoulou A, Papavassiliou V, Pate SF, Patel N, Paudel A, Pavlovic Z, Piasetzky E, Ponce-Pinto ID, Prince S, Qian X, Raaf JL, Radeka V, Rafique A, Reggiani-Guzzo M, Ren L, Rice LCJ, Rochester L, Rodriguez Rondon J, Rosenberg M, Ross-Lonergan M, Scanavini G, Schmitz DW, Schukraft A, Seligman W, Shaevitz MH, Sharankova R, Shi J, Sinclair J, Smith A, Snider EL, Soderberg M, Söldner-Rembold S, Spentzouris P, Spitz J, Stancari M, John JS, Strauss T, Sutton K, Sword-Fehlberg S, Szelc AM, Tang W, Terao K, Thorpe C, Totani D, Toups M, Tsai YT, Uchida MA, Usher T, Van De Pontseele W, Viren B, Weber M, Wei H, Williams Z, Wolbers S, Wongjirad T, Wospakrik M, Wresilo K, Wright N, Wu W, Yandel E, Yang T, Yarbrough G, Yates LE, Yu HW, Zeller GP, Zennamo J, Zhang C,\n\nPhysical review letters.. 2022 April 15128 (15):151801. Epub 1900 01 01.\n\nIsolated Colonic Post-Transplantation Lymphoproliferative Disease.\n\nFredrick TW, Ramos GP, Loftus EV\n\nClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.. 2022 April 20 (4):e648. Epub 01/29/2021.\n\nAltered expression of NEAT1 variants and P53, PTEN, and BCL-2 genes in patients with acute myeloid leukemia.\n\nRostami M, Kharajo RS, Parsa-Kondelaji M, Ayatollahi H, Sheikhi M, Keramati MR\n\nLeukemia research.. 2022 April 115 :106807. Epub 02/10/2022.\n\nA Review of Hemophagocytic Lymphohistiocytosis in Patients With HIV.\n\nTabaja H, Kanj A, El Zein S, Comba IY, Chehab O, Mahmood M\n\nOpen forum infectious diseases.. 2022 April 9 (4):ofac071. Epub 02/11/2022.\n\nEvaluation of and Genes Polymorphisms in Iraqi Women with Breast Cancer.\n\nAl-Zubaidy HFS, Majeed SR, Al-Koofee DAF\n\nArchives of Razi Institute.. 2022 April 77 (2):799-808. Epub 04/30/2022.\n\nZilovertamab Vedotin Targeting of ROR1 as Therapy for Lymphoid Cancers.\n\nWang ML, Barrientos JC, Furman RR, Mei M, Barr PM, Choi MY, de Vos S, Kallam A, Patel K, Kipps TJ, Rule S, Flanders K, Jessen KA, Ren H, Riebling PC, Graham P, King L, Thurston AW, Sun M, Schmidt EM, Lannutti BJ, Johnson DM, Miller LL, Spurgeon SE\n\nNEJM evidence.. 2022 January 1 (1):EVIDoa2100001. Epub 10/12/2021.\n\nMeasurable residual disease does not preclude prolonged progression-free survival in CLL treated with ibrutinib.\n\nWang V, Hanson CA, Tschumper R, Lesnick C, Braggio E, Paietta E, O'Brien SM, Barrientos J, Leis JF, Zhang CC, Coutre SE, Barr PM, Cashen AF, Mato AR, Singh AK, Mullane MP, Erba HP, Stone RM, Litzow MR, Tallman MS, Shanafelt TD, Kay NE\n\nBlood.. 2021 December 30138 (26):2810-2827. Epub 1900 01 01.\n\nUsing ibrutinib in earlier lines of treatment results in better outcomes for patients with chronic lymphocytic leukemia/small lymphocytic lymphoma.\n\nWoyach J, Tedeschi A, Munir T, Siddiqi T, Hillmen P, Byrd JC, Ghia P, Mulligan SP, Dai S, Amaya-Chanaga CI, Dean JP, O'Brien SM, Barr PM\n\nLeukemia & lymphoma.. 2021 December 62 (13):3278-3282. Epub 08/13/2021.\n\nCOVID-19 in patients with CLL: improved survival outcomes and update on management strategies.\n\nRoeker LE, Eyre TA, Thompson MC, Lamanna N, Coltoff A, Davids MS, Baker P, Leslie LA, Rogers KA, Allan JN, Cordoba R, Lopez-Garcia A, Antic D, Pagel JM, Martinez-Calle N, Garcia-Marco JA, Hernández-Rivas JÁ, Miras F, Coombs CC, Österborg A, Seddon AN, López-Jiménez J, Wilson MR, El-Sharkawi D, Wojenski D, Ma S, Munir T, Valenciano S, Seymour E, Barr PM, Pu JJ, Patten PE, Perini GF, Huntington SF, Parry H, Sundaram S, Skarbnik AP, Kamdar M, Jacobs RW, Walter HS, Walewska R, Broom A, Lebowitz S, Isaac K, Portell CA, Ahn IE, Ujjani C, Shadman M, Skånland SS, Chong EA, Mato AR\n\nBlood.. 2021 November 4138 (18):1768-1773. Epub 1900 01 01.\n\nBrentuximab Vedotin Combined With Chemotherapy in Patients With Newly Diagnosed Early-Stage, Unfavorable-Risk Hodgkin Lymphoma.\n\nKumar A, Casulo C, Advani RH, Budde E, Barr PM, Batlevi CL, Caron P, Constine LS, Dandapani SV, Drill E, Drullinsky P, Friedberg JW, Grieve C, Hamilton A, Hamlin PA, Hoppe RT, Horwitz SM, Joseph A, Khan N, Laraque L, Matasar MJ, Moskowitz AJ, Noy A, Palomba ML, Schöder H, Straus DJ, Vemuri S, Yang J, Younes A, Zelenetz AD, Yahalom J, Moskowitz CH\n\nJournal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2021 July 1039 (20):2257-2265. Epub 04/28/2021.\n\nShort term results of vaccination with adjuvanted recombinant varicella zoster glycoprotein E during initial BTK inhibitor therapy for CLL or lymphoplasmacytic lymphoma.\n\nZent CS, Brady MT, Delage C, Strawderman M, Laniewski N, Contant PN, Kanagaiah P, Sangster MY, Barr PM, Chu CC, Topham DJ, Friedberg JW\n\nLeukemia.. 2021 June 35 (6):1788-1791. Epub 10/30/2020.\n\nPhase 2 study of the safety and efficacy of umbralisib in patients with CLL who are intolerant to BTK or PI3K? inhibitor therapy.\n\nMato AR, Ghosh N, Schuster SJ, Lamanna N, Pagel JM, Flinn IW, Barrientos J, Rai KR, Reeves JA, Cheson BD, Barr PM, Kambhampati S, Lansigan F, Pu JJ, Skarbnik AP, Roeker LE, Fonseca G, Sitlinger A, Hamadeh IS, Dorsey C, LaRatta N, Weissbrot H, Luning Prak ET, Tsao PY, Paskalis D, Sportelli P, Miskin HP, Weiss MS, Svoboda J, Brander DM\n\nBlood.. 2021 May 20137 (20):2817-2826. Epub 1900 01 01.\n\nToxicity patterns of novel PI3K combinations in patients with non-Hodgkin lymphoma.\n\nRodgers TD, Williams AM, Baran A, Reagan PM, Casulo C, Zent CS, Evans A, Friedberg JW, Barr PM\n\nLeukemia & lymphoma.. 2021 March 62 (3):598-605. Epub 10/25/2020.\n\nHighlights in leukemia and lymphoma from the 62nd American Society of Hematology Annual Meeting and Exposition: commentary.\n\nBarr PM\n\nClinical advances in hematology & oncology : H&O.. 2021 March 19 Suppl 11 (3):17-19. Epub 1900 01 01.\n\nComparative analysis of targeted novel therapies in relapsed, refractory chronic lymphocytic leukaemia.\n\nEyre TA, Lamanna N, Roeker LE, Ujjani CS, Hill BT, Barr PM, Lansigan E, Cheson BD, Yazdy M, Allan JN, Rhodes J, Schuster SJ, Nabhan C, Skarbnik A, Leslie L, Islam P, Whitaker K, Coombs CC, Tuncer HH, Pagel JM, Jacobs R, Winter AM, Bailey N, Sitlinger A, Schuh AH, Follows G, Fox CP, Brander DM, Shadman M, Mato AR\n\nHaematologica.. 2021 January 1106 (1):284-287. Epub 01/01/2021.\n\nEfficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real-world setting. A GIMEMA-ERIC and US study.\n\nCuneo A, Mato AR, Rigolin GM, Piciocchi A, Gentile M, Laurenti L, Allan JN, Pagel JM, Brander DM, Hill BT, Winter A, Lamanna N, Tam CS, Jacobs R, Lansigan F, Barr PM, Shadman M, Skarbnik AP, Pu JJ, Sehgal AR, Schuster SJ, Shah NN, Ujjani CS, Roeker L, Orlandi EM, Billio A, Trentin L, Spacek M, Marchetti M, Tedeschi A, Ilariucci F, Gaidano G, Doubek M, Farina L, Molica S, Di Raimondo F, Coscia M, Mauro FR, de la Serna J, Medina Perez A, Ferrarini I, Cimino G, Cavallari M, Cucci R, Vignetti M, Foà R, Ghia P,\n\nCancer medicine. 2020 November 9 (22):8468-8479. Epub 09/24/2020.\n\nPositron Emission Tomography-Directed Therapy for Patients With Limited-Stage Diffuse Large B-Cell Lymphoma: Results of Intergroup National Clinical Trials Network Study S1001.\n\nPersky DO, Li H, Stephens DM, Park SI, Bartlett NL, Swinnen LJ, Barr PM, Winegarden JD, Constine LS, Fitzgerald TJ, Leonard JP, Kahl BS, LeBlanc ML, Song JY, Fisher RI, Rimsza LM, Smith SM, Miller TP, Friedberg JW\n\nJournal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2020 September 1038 (26):3003-3011. Epub 07/13/2020.\n\nOutcomes of COVID-19 in patients with CLL: a multicenter international experience.\n\nMato AR, Roeker LE, Lamanna N, Allan J, Leslie LA, Pagel JM, Patel K, Osterborg A, Wojenski D, Kamdar M, Huntington SF, Davids MS, Brown JR, Antic D, Jacobs RW, Ahn IE, Pu JJ, Isaac K, Barr PM, Ujjani C, Geyer MB, Berman E, Zelenetz AD, Malakhov N, Furman RR, Koropsak M, Bailey N, Hansson L, Perini GF, Ma S, Ryan CE, Wiestner A, Portell CA, Shadman M, Chong EA, Brander DM, Sundaram S, Seddon AN, Seymour E, Patel M, Martinez-Calle N, Munir T, Walewska R, Broom A, Walter HS, El-Sharkawi D, Parry H, Wilson MR, Patten PE, Hernández-Rivas JÁ, Miras F, Fernández Escalada N, Ghione P, Nabhan C, Lebowitz S, Bhavsar EB, López-Jiménez J, Naya D, Garcia-Marco JA, Skånland SS, Cordoba R, Eyre TA\n\nBlood.. 2020 September 3136 (10):1134-1143. Epub 1900 01 01.\n\nEarly Progression of Follicular Lymphoma: Biology and Treatment.\n\nLipof JJ, Barr PM\n\nHematology/oncology clinics of North America.. 2020 August 34 (4):757-769. Epub 05/05/2020.\n\nAssessment of the Efficacy of Therapies Following Venetoclax Discontinuation in CLL Reveals BTK Inhibition as an Effective Strategy.\n\nMato AR, Roeker LE, Jacobs R, Hill BT, Lamanna N, Brander D, Shadman M, Ujjani CS, Sarraf Yazdy M, Perini GF, Pinilla-Ibarz JA, Barrientos J, Skarbnik AP, Torka P, Pu JJ, Pagel JM, Gohil S, Fakhri B, Choi M, Coombs CC, Rhodes J, Barr PM, Portell CA, Parry H, Garcia CA, Whitaker KJ, Winter AM, Sitlinger A, Khajavian S, Grajales-Cruz AF, Isaac KM, Shah P, Akhtar OS, Pocock R, Lam K, Voorhees TJ, Schuster SJ, Rodgers TD, Fox CP, Martinez-Calle N, Munir T, Bhavsar EB, Bailey N, Lee JC, Weissbrot HB, Nabhan C, Goodfriend JM, King AC, Zelenetz AD, Dorsey C, Bigelow K, Cheson BD, Allan JN, Eyre TA\n\nClinical cancer research : an official journal of the American Association for Cancer Research.. 2020 July 1526 (14):3589-3596. Epub 03/20/2020.\n\nCognitive function in patients with chronic lymphocytic leukemia: a cross-sectional study examining effects of disease and treatment.\n\nWilliams AM, van Wijngaarden E, Seplaki CL, Heckler CE, Weber MT, Barr PM, Zent CS, Janelsins MC\n\nLeukemia & lymphoma.. 2020 July 61 (7):1627-1635. Epub 03/09/2020.\n\nAdditional B-cell malignancies in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL).\n\nMeacham PJ, Williams AM, Strawderman M, Baran AM, Archibald WJ, Wallace DS, Tschernia NP, Burack WR, Barr PM, Zent CS\n\nLeukemia & lymphoma.. 2020 July 61 (7):1636-1644. Epub 03/16/2020.\n\nInitial treatment of B-cell prolymphocytic leukemia with ibrutinib.\n\nMoore J, Baran AM, Meacham PJ, Evans AG, Barr PM, Zent CS\n\nAmerican journal of hematology.. 2020 May 95 (5):E108-E110. Epub 01/31/2020.\n\nA cross-trial comparison of single-agent ibrutinib chlorambucil-obinutuzumab in previously untreated patients with chronic lymphocytic leukemia or small lymphocytic lymphoma.\n\nTedeschi A, Greil R, Demirkan F, Robak T, Moreno C, Barr PM, Anz B, Simpson D, Gaidano G, Bairey O, Stevens D, Gill D, Flinn IW, Kipps TJ, Burger JA, Lin J, Webb T, Fedorov V, Styles L, Gribben JG\n\nHaematologica.. 2020 April 105 (4):e164-e168. Epub 08/14/2019.\n\nLong-term efficacy and safety of first-line ibrutinib treatment for patients with CLL/SLL: 5 years of follow-up from the phase 3 RESONATE-2 study.\n\nBurger JA, Barr PM, Robak T, Owen C, Ghia P, Tedeschi A, Bairey O, Hillmen P, Coutre SE, Devereux S, Grosicki S, McCarthy H, Simpson D, Offner F, Moreno C, Dai S, Lal I, Dean JP, Kipps TJ\n\nLeukemia.. 2020 March 34 (3):787-798. Epub 10/18/2019.\n\nThe efficacy and safety of venetoclax therapy in elderly patients with relapsed, refractory chronic lymphocytic leukaemia.\n\nEyre TA, Roeker LE, Fox CP, Gohill SH, Walewska R, Walter HS, Forconi F, Broom A, Arumainathan A, Brander DM, Allan JN, Schuster SJ, Hill BT, Lansigan F, Cheson BD, Lamanna N, Coombs CC, Barr PM, Skarbnik AP, Shadman M, Ujjani CS, Pearson L, Pagel JM, Jacobs R, Mato AR\n\nBritish journal of haematology.. 2020 March 188 (6):918-923. Epub 11/04/2019.\n\nComplete recovery of late onset progressive multifocal leukoencephalopathy related to treatment with chemoimmunotherapy: A case report.\n\nGodbole MM, Barr PM\n\nLeukemia research.. 2020 March 90 :106309. Epub 01/21/2020.\n\nEfficacy of lenalidomide in high-risk diffuse large B-cell lymphoma.\n\nRodgers TD, Baran A, Reagan PM, Casulo C, Zent C, Evans A, Burack R, Williams AM, Friedberg JW, Barr PM\n\nBritish journal of haematology.. 2020 February 188 (4):e33-e36. Epub 12/17/2019.\n\nSignificant weight gain in CLL patients treated with Ibrutinib: A potentially deleterious consequence of therapy.\n\nWilliams AM, Baran AM, Schaffer M, Bushart J, Rich L, Moore J, Barr PM, Zent CS\n\nAmerican journal of hematology.. 2020 January 95 (1):E16-E18. Epub 11/03/2019.\n\nThe Impact of Age on Survival in CLL Patients Receiving Ibrutinib as Initial Therapy.\n\nUjjani C, Mato A, Hill BT, Allan JN, Lansigan F, Jacobs R, Skarbnik A, Tuncer H, Pagel J, Brander D, Cheson B, Barr P, Roeker LE, Pu J, Shah NN, Goy A, Schuster SJ, Lamanna N, Sehgal A, Tam CS, Shadman M\n\nBlood and lymphatic cancer : targets and therapy.. 2020 10 :1-5. Epub 08/24/2020.\n\nPatients with diffuse large B-cell lymphoma requiring urgent treatment: its implication on trial design and interpretation.\n\nLoh KP, Baran A, Lee CY, Alshaibani A, Rutherford SC, Hu J, Casulo C, Barr PM, Friedberg JW, Reagan PM\n\nLeukemia & lymphoma.. 2019 December 60 (14):3569-3572. Epub 07/08/2019.\n\nFinal analysis from RESONATE: Up to six years of follow-up on ibrutinib in patients with previously treated chronic lymphocytic leukemia or small lymphocytic lymphoma.\n\nMunir T, Brown JR, O'Brien S, Barrientos JC, Barr PM, Reddy NM, Coutre S, Tam CS, Mulligan SP, Jaeger U, Kipps TJ, Moreno C, Montillo M, Burger JA, Byrd JC, Hillmen P, Dai S, Szoke A, Dean JP, Woyach JA\n\nAmerican journal of hematology.. 2019 December 94 (12):1353-1363. Epub 10/13/2019.\n\nNivolumab Combined With Brentuximab Vedotin for Relapsed/Refractory Primary Mediastinal Large B-Cell Lymphoma: Efficacy and Safety From the Phase II CheckMate 436 Study.\n\nZinzani PL, Santoro A, Gritti G, Brice P, Barr PM, Kuruvilla J, Cunningham D, Kline J, Johnson NA, Mehta-Shah N, Manley T, Francis S, Sharma M, Moskowitz AJ\n\nJournal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2019 November 2037 (33):3081-3089. Epub 08/09/2019.\n\nIbrutinib (Ibr) Plus Venetoclax (Ven) for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL): Results from the MRD Cohort of the Phase 2 CAPTIVATE Study.\n\nTam CS, Siddiqi T, Allan JN, Kipps TJ, Flinn IW, Kuss BJ, Opat S, Barr PM, Tedeschi A, Jacobs R, Badoux XC, Ghia P, Sukbuntherng J, Salem AH, Russell K, Eckert K, Zhou C, Ninomoto J, James DF, Wierda WG\n\nBlood.. 2019 November 13134 (Supplement_1):35. Epub 1900 01 01.\n\nUtility of positron emission tomography-computed tomography in patients with chronic lymphocytic leukemia following B-cell receptor pathway inhibitor therapy.\n\nMato AR, Wierda WG, Davids MS, Cheson BD, Coutre SE, Choi M, Furman RR, Heffner L, Barr PM, Eradat H, Ford SM, Zhou L, Verdugo M, Humerickhouse RA, Potluri J, Byrd JC\n\nHaematologica.. 2019 November 104 (11):2258-2264. Epub 03/28/2019.\n\nFollicular Lymphoma: Recent and Emerging Therapies, Treatment Strategies, and Remaining Unmet Needs.\n\nMatasar MJ, Luminari S, Barr PM, Barta SK, Danilov AV, Hill BT, Phillips TJ, Jerkeman M, Magagnoli M, Nastoupil LJ, Persky DO, Okosun J\n\nThe oncologist.. 2019 November 24 (11):e1236-e1250. Epub 07/25/2019.\n\nLong-Term Studies Assessing Outcomes of Ibrutinib Therapy in Patients With Del(11q) Chronic Lymphocytic Leukemia.\n\nKipps TJ, Fraser G, Coutre SE, Brown JR, Barrientos JC, Barr PM, Byrd JC, O'Brien SM, Dilhuydy MS, Hillmen P, Jaeger U, Moreno C, Cramer P, Stilgenbauer S, Chanan-Khan AA, Mahler M, Salman M, Eckert K, Solman IG, Balasubramanian S, Cheng M, Londhe A, Ninomoto J, Howes A, James DF, Hallek M\n\nClinical lymphoma, myeloma & leukemia.. 2019 November 19 (11):715-722.e6. Epub 07/15/2019.\n\nFive-year outcomes of the S1106 study of R-hyper-CVAD vs R-bendamustine in transplant-eligible patients with mantle cell lymphoma.\n\nKamdar M, Li H, Chen RW, Rimsza LM, Leblanc ML, Fenske TS, Shea TC, Barr PM, Phillips TJ, Leonard JP, Kahl BS, Friedberg JW, Smith SM\n\nBlood advances.. 2019 October 223 (20):3132-3135. Epub 1900 01 01.\n\nFive-year follow-up of SWOG S0816: limitations and values of a PET-adapted approach with stage III/IV Hodgkin lymphoma.\n\nStephens DM, Li H, Schöder H, Straus DJ, Moskowitz CH, Leblanc M, Rimsza LM, Bartlett NL, Evens AM, LaCasce AS, Barr PM, Knopp MV, Hsi E, Leonard JP, Kahl B, Smith SM, Friedberg JW\n\nBlood.. 2019 October 10134 (15):1238-1246. Epub 1900 01 01.\n\nIbrutinib-Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia.\n\nShanafelt TD, Wang XV, Kay NE, Hanson CA, O'Brien S, Barrientos J, Jelinek DF, Braggio E, Leis JF, Zhang CC, Coutre SE, Barr PM, Cashen AF, Mato AR, Singh AK, Mullane MP, Little RF, Erba H, Stone RM, Litzow M, Tallman M\n\nThe New England journal of medicine.. 2019 August 1381 (5):432-443. Epub 1900 01 01.\n\nTumor Lysis, Adverse Events, and Dose Adjustments in 297 Venetoclax-Treated CLL Patients in Routine Clinical Practice.\n\nRoeker LE, Fox CP, Eyre TA, Brander DM, Allan JN, Schuster SJ, Nabhan C, Hill BT, Shah NN, Lansigan F, Yazdy M, Cheson BD, Lamanna N, Singavi AK, Coombs CC, Barr PM, Skarbnik AP, Shadman M, Ujjani CS, Tuncer HH, Winter AM, Rhodes J, Dorsey C, Morse H, Kabel C, Pagel JM, Williams AM, Jacobs R, Goy A, Muralikrishnan S, Pearson L, Sitlinger A, Bailey N, Schuh A, Kirkwood AA, Mato AR\n\nClinical cancer research : an official journal of the American Association for Cancer Research.. 2019 July 1525 (14):4264-4270. Epub 04/19/2019.\n\nIbrutinib provides favourable survival outcomes in patients with comorbidities versus established therapies.\n\nBurger JA, Cramer P, Barr PM, Dilhuydy MS, Mato A, Byrd JC, Chang S, Graef T, Lin T, Tedeschi A\n\nBritish journal of haematology.. 2019 July 186 (1):175-180. Epub 02/10/2019.\n\nTumour debulking and reduction in predicted risk of tumour lysis syndrome with single-agent ibrutinib in patients with chronic lymphocytic leukaemia.\n\nWierda WG, Byrd JC, O'Brien S, Coutre S, Barr PM, Furman RR, Kipps TJ, Burger JA, Stevens DA, Sharman J, Ghia P, Flinn IW, Zhou C, Ninomoto J, James DF, Tam CS\n\nBritish journal of haematology.. 2019 July 186 (1):184-188. Epub 02/10/2019.\n\nMulticentre retrospective study of intravascular large B-cell lymphoma treated at academic institutions within the United States.\n\nGeer M, Roberts E, Shango M, Till BG, Smith SD, Abbas H, Hill BT, Kaplan J, Barr PM, Caimi P, Stephens DM, Lin E, Herrera AF, Rosenbaum E, Amengual JE, Boonstra PS, Devata S, Wilcox RA, Kaminski MS, Phillips TJ\n\nBritish journal of haematology.. 2019 July 186 (2):255-262. Epub 05/01/2019.\n\nLong-term safety of single-agent ibrutinib in patients with chronic lymphocytic leukemia in 3 pivotal studies.\n\nCoutre SE, Byrd JC, Hillmen P, Barrientos JC, Barr PM, Devereux S, Robak T, Kipps TJ, Schuh A, Moreno C, Furman RR, Burger JA, O'Dwyer M, Ghia P, Valentino R, Chang S, Dean JP, James DF, O'Brien SM\n\nBlood advances.. 2019 June 253 (12):1799-1807. Epub 1900 01 01.\n\nVenetoclax for chronic lymphocytic leukaemia patients who progress after more than one B-cell receptor pathway inhibitor.\n\nWierda WG, Byrd JC, Davids MS, Furman RR, Cheson BD, Barr PM, Eradat H, Heffner L, Zhou L, Verdugo M, Potluri J, Choi M\n\nBritish journal of haematology.. 2019 June 185 (5):961-966. Epub 11/27/2018.\n\nA retrospective comparison of venetoclax alone or in combination with an anti-CD20 monoclonal antibody in R/R CLL.\n\nMato AR, Roeker LE, Eyre TA, Nabhan C, Lamanna N, Hill BT, Brander DM, Barr PM, Lansigan F, Cheson BD, Singavi AK, Yazdy MS, Shah NN, Allan JN, Bhavsar EB, Rhodes J, Kennard K, Schuster SJ, Williams AM, Skarbnik AP, Goy AH, Goodfriend JM, Dorsey C, Coombs CC, Tuncer H, Ujjani CS, Jacobs R, Winter AM, Pagel JM, Bailey N, Schuh A, Shadman M, Sitlinger A, Weissbrot H, Muralikrishnan S, Zelenetz A, Kirkwood AA, Fox CP\n\nBlood advances.. 2019 May 283 (10):1568-1573. Epub 1900 01 01.\n\nAugmenting Indolent Lymphoma Treatment Options With the Combination of Lenalidomide and Rituximab.\n\nBarr PM\n\nJournal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2019 May 1037 (14):1151-1153. Epub 03/22/2019.\n\nLong-term follow-up of the RESONATE phase 3 trial of ibrutinib vs ofatumumab.\n\nByrd JC, Hillmen P, O'Brien S, Barrientos JC, Reddy NM, Coutre S, Tam CS, Mulligan SP, Jaeger U, Barr PM, Furman RR, Kipps TJ, Thornton P, Moreno C, Montillo M, Pagel JM, Burger JA, Woyach JA, Dai S, Vezan R, James DF, Brown JR\n\nBlood.. 2019 May 9133 (19):2031-2042. Epub 03/06/2019.\n\nOutcomes with ibrutinib by line of therapy and post-ibrutinib discontinuation in patients with chronic lymphocytic leukemia: Phase 3 analysis.\n\nO'Brien SM, Byrd JC, Hillmen P, Coutre S, Brown JR, Barr PM, Barrientos JC, Devereux S, Robak T, Reddy NM, Kipps TJ, Tedeschi A, Cymbalista F, Ghia P, Chang S, Ninomoto J, James DF, Burger JA\n\nAmerican journal of hematology.. 2019 May 94 (5):554-562. Epub 03/08/2019.\n\nHow I treat early-relapsing follicular lymphoma.\n\nCasulo C, Barr PM\n\nBlood.. 2019 April 4133 (14):1540-1547. Epub 01/30/2019.\n\nA phase 1 trial of SGN-CD70A in patients with CD70-positive diffuse large B cell lymphoma and mantle cell lymphoma.\n\nPhillips T, Barr PM, Park SI, Kolibaba K, Caimi PF, Chhabra S, Kingsley EC, Boyd T, Chen R, Carret AS, Gartner EM, Li H, Yu C, Smith DC\n\nInvestigational new drugs.. 2019 April 37 (2):297-306. Epub 08/22/2018.\n\nIbrutinib Dose Adherence and Therapeutic Efficacy in Non-Hodgkin Lymphoma: A Single-Center Experience.\n\nWilliams AM, Baran AM, Casulo C, Reagan P, Friedberg JW, Helber M, Moore J, Baloga E, Zent CS, Barr PM\n\nClinical lymphoma, myeloma & leukemia.. 2019 January 19 (1):41-47. Epub 10/13/2018.\n\nIbrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL.\n\nWoyach JA, Ruppert AS, Heerema NA, Zhao W, Booth AM, Ding W, Bartlett NL, Brander DM, Barr PM, Rogers KA, Parikh SA, Coutre S, Hurria A, Brown JR, Lozanski G, Blachly JS, Ozer HG, Major-Elechi B, Fruth B, Nattam S, Larson RA, Erba H, Litzow M, Owen C, Kuzma C, Abramson JS, Little RF, Smith SE, Stone RM, Mandrekar SJ, Byrd JC\n\nThe New England journal of medicine.. 2018 December 27379 (26):2517-2528. Epub 12/01/2018.\n\nComplications Associated With Dose-adjusted EPOCH-rituximab Therapy for Non-Hodgkin Lymphoma.\n\nDavid RJ, Baran A, Loh KP, Casulo C, Barr PM, Friedberg JW, Reagan PM\n\nClinical lymphoma, myeloma & leukemia.. 2018 December 18 (12):781-787. Epub 08/29/2018.\n\nSingle-agent ibrutinib versus chemoimmunotherapy regimens for treatment-naïve patients with chronic lymphocytic leukemia: A cross-trial comparison of phase 3 studies.\n\nRobak T, Burger JA, Tedeschi A, Barr PM, Owen C, Bairey O, Hillmen P, Simpson D, Grosicki S, Devereux S, McCarthy H, Coutre SE, Quach H, Gaidano G, Maslyak Z, Stevens DA, Moreno C, Gill DS, Flinn IW, Gribben JG, Mokatrin A, Cheng M, Styles L, James DF, Kipps TJ, Ghia P\n\nAmerican journal of hematology.. 2018 November 93 (11):1402-1410. Epub 10/09/2018.\n\nOutcomes of front-line ibrutinib treated CLL patients excluded from landmark clinical trial.\n\nMato AR, Roeker LE, Allan JN, Pagel JM, Brander DM, Hill BT, Cheson BD, Furman RR, Lamanna N, Tam CS, Handunnetti S, Jacobs R, Lansigan F, Bhavsar E, Barr PM, Shadman M, Skarbnik AP, Goy A, Beach DF, Svoboda J, Pu JJ, Sehgal AR, Zent CS, Tuncer HH, Schuster SJ, Pickens PV, Shah NN, Rhodes J, Ujjani CS, Nabhan C\n\nAmerican journal of hematology.. 2018 November 93 (11):1394-1401. Epub 09/26/2018.\n\nSafety Analysis of Four Randomized Controlled Studies of Ibrutinib in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Mantle Cell Lymphoma.\n\nO'Brien S, Hillmen P, Coutre S, Barr PM, Fraser G, Tedeschi A, Burger JA, Dilhuydy MS, Hess G, Moreno C, Cramer P, Liu E, Chang S, Vermeulen J, Styles L, Howes A, James DF, Patel K, Graef T, Valentino R\n\nClinical lymphoma, myeloma & leukemia.. 2018 October 18 (10):648-657.e15. Epub 06/28/2018.\n\nCellular Cytotoxicity of Next-Generation CD20 Monoclonal Antibodies.\n\nVanDerMeid KR, Elliott MR, Baran AM, Barr PM, Chu CC, Zent CS\n\nCancer immunology research.. 2018 October 6 (10):1150-1160. Epub 08/08/2018.\n\nSustained efficacy and detailed clinical follow-up of first-line ibrutinib treatment in older patients with chronic lymphocytic leukemia: extended phase 3 results from RESONATE-2.\n\nBarr PM, Robak T, Owen C, Tedeschi A, Bairey O, Bartlett NL, Burger JA, Hillmen P, Coutre S, Devereux S, Grosicki S, McCarthy H, Li J, Simpson D, Offner F, Moreno C, Zhou C, Styles L, James D, Kipps TJ, Ghia P\n\nHaematologica.. 2018 September 103 (9):1502-1510. Epub 06/07/2018.\n\nReal-world outcomes and management strategies for venetoclax-treated chronic lymphocytic leukemia patients in the United States.\n\nMato AR, Thompson M, Allan JN, Brander DM, Pagel JM, Ujjani CS, Hill BT, Lamanna N, Lansigan F, Jacobs R, Shadman M, Skarbnik AP, Pu JJ, Barr PM, Sehgal AR, Cheson BD, Zent CS, Tuncer HH, Schuster SJ, Pickens PV, Shah NN, Goy A, Winter AM, Garcia C, Kennard K, Isaac K, Dorsey C, Gashonia LM, Singavi AK, Roeker LE, Zelenetz A, Williams A, Howlett C, Weissbrot H, Ali N, Khajavian S, Sitlinger A, Tranchito E, Rhodes J, Felsenfeld J, Bailey N, Patel B, Burns TF, Yacur M, Malhotra M, Svoboda J, Furman RR, Nabhan C\n\nHaematologica.. 2018 September 103 (9):1511-1517. Epub 06/07/2018.\n\nCounterpoint: Can Chemotherapy Be Eliminated in the Treatment of Follicular Lymphoma?\n\nBarr PM\n\nOncology.. 2018 August 1532 (8):404, 407-9. Epub 1900 01 01.\n\nA phase I/II trial of vorinostat (SAHA) in combination with rituximab-CHOP in patients with newly diagnosed advanced stage diffuse large B-cell lymphoma (DLBCL): SWOG S0806.\n\nPersky DO, Li H, Rimsza LM, Barr PM, Popplewell LL, Bane CL, Von Gehr A, LeBlanc M, Fisher RI, Smith SM, Friedberg JW\n\nAmerican journal of hematology.. 2018 August 93 (4):486-493. Epub 01/25/2018.\n\nManagement of melanoma in patients with chronic lymphocytic leukemia.\n\nArchibald WJ, Meacham PJ, Williams AM, Baran AM, Victor AI, Barr PM, Sahasrahbudhe DM, Zent CS\n\nLeukemia research.. 2018 August 71 :43-46. Epub 07/06/2018.\n\nPhase 1 study of the PI3K? inhibitor INCB040093 ± JAK1 inhibitor itacitinib in relapsed/refractory B-cell lymphoma.\n\nPhillips TJ, Forero-Torres A, Sher T, Diefenbach CS, Johnston P, Talpaz M, Pulini J, Zhou L, Scherle P, Chen X, Barr PM\n\nBlood.. 2018 July 19132 (3):293-306. Epub 04/25/2018.\n\nSurvival adjusting for crossover: phase 3 study of ibrutinib . chlorambucil in older patients with untreated chronic lymphocytic leukemia/small lymphocytic lymphoma.\n\nCoutre S, Tedeschi A, Robak T, Barr PM, Owen C, Bairey O, Burger J, Zhou C, Styles L, James DF, Kipps TJ\n\nHaematologica.. 2018 June 103 (6):e249-e251. Epub 11/23/2017.\n\nPitfalls of Combining Novel Agents in Lymphoma.\n\nRodgers TD, Barr PM\n\nCurrent treatment options in oncology.. 2018 May 2819 (7):35. Epub 05/28/2018.\n\nToxicities and outcomes of 616 ibrutinib-treated patients in the United States: a real-world analysis.\n\nMato AR, Nabhan C, Thompson MC, Lamanna N, Brander DM, Hill B, Howlett C, Skarbnik A, Cheson BD, Zent C, Pu J, Kiselev P, Goy A, Claxton D, Isaack K, Kennard KH, Timlin C, Landsburg D, Winter A, Nasta SD, Bachow SH, Schuster SJ, Dorsey C, Svoboda J, Barr P, Ujjani CS\n\nHaematologica.. 2018 May 103 (5):874-879. Epub 02/01/2018.\n\nAnalysis of the risk of infection in patients with chronic lymphocytic leukemia in the era of novel therapies.\n\nWilliams AM, Baran AM, Meacham PJ, Feldman MM, Valencia HE, Newsom-Stewart C, Gupta N, Janelsins MC, Barr PM, Zent CS\n\nLeukemia & lymphoma.. 2018 March 59 (3):625-632. Epub 07/11/2017.\n\nR-CHOP, radioimmunotherapy, and maintenance rituximab in untreated follicular lymphoma (SWOG S0801): a single-arm, phase 2, multicentre study.\n\nBarr PM, Li H, Burack WR, LeBlanc M, Smith SM, Gopal AK, Floyd JD, Persky DO, Press OW, Fisher RI, Friedberg JW\n\nThe Lancet. Haematology.. 2018 March 5 (3):e102-e108. Epub 01/26/2018.\n\nExtended follow-up and impact of high-risk prognostic factors from the phase 3 RESONATE study in patients with previously treated CLL/SLL.\n\nBrown JR, Hillmen P, O'Brien S, Barrientos JC, Reddy NM, Coutre SE, Tam CS, Mulligan SP, Jaeger U, Barr PM, Furman RR, Kipps TJ, Cymbalista F, Thornton P, Caligaris-Cappio F, Delgado J, Montillo M, DeVos S, Moreno C, Pagel JM, Munir T, Burger JA, Chung D, Lin J, Gau L, Chang B, Cole G, Hsu E, James DF, Byrd JC\n\nLeukemia.. 2018 January 32 (1):83-91. Epub 06/08/2017.\n\nVenetoclax for chronic lymphocytic leukaemia progressing after ibrutinib: an interim analysis of a multicentre, open-label, phase 2 trial.\n\nJones JA, Mato AR, Wierda WG, Davids MS, Choi M, Cheson BD, Furman RR, Lamanna N, Barr PM, Zhou L, Chyla B, Salem AH, Verdugo M, Humerickhouse RA, Potluri J, Coutre S, Woyach J, Byrd JC\n\nThe Lancet. Oncology.. 2018 January 19 (1):65-75. Epub 12/12/2017.\n\nPhase I clinical trial of the base excision repair inhibitor methoxyamine in combination with fludarabine for patients with advanced hematologic malignancies.\n\nCaimi PF, Cooper BW, William BM, Dowlati A, Barr PM, Fu P, Pink J, Xu Y, Lazarus HM, de Lima M, Gerson SL\n\nOncotarget.. 2017 October 38 (45):79864-79875. Epub 08/09/2017.\n\nEarly-stage mantle cell lymphoma: a retrospective analysis from the International Lymphoma Radiation Oncology Group (ILROG).\n\nDabaja BS, Zelenetz AD, Ng AK, Tsang RW, Qi S, Allen PK, Hodgson D, Ricardi U, Hoppe RT, Advani R, Mauch PM, Constine LS, Specht L, Li Y, Terezakis SA, Wirth A, Reinartz G, Eich HT, Aleman BMP, Barr P, Yahalom J\n\nAnnals of oncology : official journal of the European Society for Medical Oncology. 2017 September 128 (9):2185-2190. Epub 1900 01 01.\n\nTreatment of chronic lymphocytic leukemia in older adults.\n\nRowswell-Turner RB, Barr PM\n\nJournal of geriatric oncology.. 2017 September 8 (5):315-319. Epub 05/06/2017.\n\nUse of anticoagulants and antiplatelet in patients with chronic lymphocytic leukaemia treated with single-agent ibrutinib.\n\nJones JA, Hillmen P, Coutre S, Tam C, Furman RR, Barr PM, Schuster SJ, Kipps TJ, Flinn IW, Jaeger U, Burger JA, Cheng M, Ninomoto J, James DF, Byrd JC, O'Brien SM\n\nBritish journal of haematology.. 2017 July 178 (2):286-291. Epub 04/10/2017.\n\nIdelalisib is effective in patients with high-risk follicular lymphoma and early relapse after initial chemoimmunotherapy.\n\nGopal AK, Kahl BS, Flowers CR, Martin P, Ansell SM, Abella-Dominicis E, Koh B, Ye W, Barr PM, Salles GA, Friedberg JW\n\nBlood.. 2017 June 1129 (22):3037-3039. Epub 03/21/2017.\n\nLong-term safety experience with bendamustine for injection in a real-world setting.\n\nMartin P, Barr PM, James L, Pathak A, Kahl B\n\nExpert opinion on drug safety.. 2017 June 16 (6):647-650. Epub 04/17/2017.\n\nImpact of ibrutinib dose adherence on therapeutic efficacy in patients with previously treated CLL/SLL.\n\nBarr PM, Brown JR, Hillmen P, O'Brien S, Barrientos JC, Reddy NM, Coutre S, Mulligan SP, Jaeger U, Furman RR, Cymbalista F, Montillo M, Dearden C, Robak T, Moreno C, Pagel JM, Burger JA, Suzuki S, Sukbuntherng J, Cole G, James DF, Byrd JC\n\nBlood.. 2017 May 11129 (19):2612-2615. Epub 04/03/2017.\n\nOptimal sequencing of ibrutinib, idelalisib, and venetoclax in chronic lymphocytic leukemia: results from a multicenter study of 683 patients.\n\nMato AR, Hill BT, Lamanna N, Barr PM, Ujjani CS, Brander DM, Howlett C, Skarbnik AP, Cheson BD, Zent CS, Pu JJ, Kiselev P, Foon K, Lenhart J, Henick Bachow S, Winter AM, Cruz AL, Claxton DF, Goy A, Daniel C, Isaac K, Kennard KH, Timlin C, Fanning M, Gashonia L, Yacur M, Svoboda J, Schuster SJ, Nabhan C\n\nAnnals of oncology : official journal of the European Society for Medical Oncology. 2017 May 128 (5):1050-1056. Epub 1900 01 01.\n\nUnderstanding the New WHO Classification of Lymphoid Malignancies: Why It's Important and How It Will Affect Practice.\n\nJaffe ES, Barr PM, Smith SM\n\nAmerican Society of Clinical Oncology educational book. 2017 May (37):535-546. Epub 1900 01 01.\n\nEfficacy in the margins of NHL with ibrutinib.\n\nBarr PM\n\nBlood.. 2017 April 20129 (16):2207-2208. Epub 1900 01 01.\n\nChemotherapy-free treatment in non-Hodgkin lymphoma: a steep learning curve.\n\nReagan PM, Barr PM\n\nThe Lancet. Haematology.. 2017 April 4 (4):e152-e153. Epub 03/15/2017.\n\nRB but not R-HCVAD is a feasible induction regimen prior to auto-HCT in frontline MCL: results of SWOG Study S1106.\n\nChen RW, Li H, Bernstein SH, Kahwash S, Rimsza LM, Forman SJ, Constine L, Shea TC, Cashen AF, Blum KA, Fenske TS, Barr PM, Phillips T, Leblanc M, Fisher RI, Cheson BD, Smith SM, Faham M, Wilkins J, Leonard JP, Kahl BS, Friedberg JW\n\nBritish journal of haematology.. 2017 March 176 (5):759-769. Epub 12/19/2016.\n\nLate Relapses After High-dose Chemotherapy and Autologous Stem Cell Transplantation in Patients With Diffuse Large B-cell Lymphoma in the Rituximab Era.\n\nHunter BD, Herr M, Meacham PJ, Barlaskar F, Evans AG, Burack WR, Liesveld JL, Becker MW, Milner LA, Constine LS, Dhakal S, Barr PM, Friedberg JW, Casulo C\n\nClinical lymphoma, myeloma & leukemia.. 2017 March 17 (3):145-151. Epub 11/23/2016.\n\nRecommendations for Clinical Trial Development in Follicular Lymphoma.\n\nMaddocks K, Barr PM, Cheson BD, Little RF, Baizer L, Kahl BS, Leonard JP, Fowler N, Gordon LI, Link BK, Friedberg JW, Ansell SM\n\nJournal of the National Cancer Institute.. 2017 March 109 (3)Epub 12/31/2016.\n\nOptimal Sequencing of Ibrutinib, Idelalisib, and Venetoclax in Chronic Lymphocytic Leukemia: Results from a Multi-Center Study of 683 Patients.\n\nMato AR, Hill BT, Lamanna N, Barr PM, Ujjani CS, Brander DM, Howlett C, Skarbnik AP, Cheson BD, Zent CS, Pu JJ, Kiselev P, Foon K, Lenhart J, Henick Bachow S, Winter AM, Cruz AL, Claxton DF, Goy A, Daniel C, Isaac K, Kennard KH, Timlin C, Fanning M, Gashonia L, Yacur M, Svoboda J, Schuster SJ, Nabhan C\n\nAnnals of oncology : official journal of the European Society for Medical Oncology. 2017 January 27 Epub 01/27/2017.\n\nOptimal Sequencing of Ibrutinib, Idelalisib, and Venetoclax in Chronic Lymphocytic Leukemia: Results from a Multi-Center Study of 683 Patients.\n\nMato AR, Hill BT, Lamanna N, Barr PM, Ujjani CS, Brander DM, Howlett C, Skarbnik AP, Cheson BD, Zent CS, Pu JJ, Kiselev P, Foon K, Lenhart J, Henick Bachow S, Winter AM, Cruz AL, Claxton DF, Goy A, Daniel C, Isaac K, Kennard KH, Timlin C, Fanning M, Gashonia L, Yacur M, Svoboda J, Schuster SJ, Nabhan C\n\nAnnals of oncology : official journal of the European Society for Medical Oncology. 2017 January 25 Epub 01/25/2017.\n\nUnderstanding the New WHO Classification of Lymphoid Malignancies: Why It's Important and How It Will Affect Practice.\n\nJaffe ES, Barr PM, Smith SM\n\nAmerican Society of Clinical Oncology educational book. 2017 37 :535-546. Epub 1900 01 01.\n\nDeregulation of NF-?B, ie, a useful PMBL marker.\n\nBarr PM\n\nBlood.. 2016 December 8128 (23):2591-2592. Epub 1900 01 01.\n\nOutcomes of CLL patients treated with sequential kinase inhibitor therapy: a real world experience.\n\nMato AR, Nabhan C, Barr PM, Ujjani CS, Hill BT, Lamanna N, Skarbnik AP, Howlett C, Pu JJ, Sehgal AR, Strelec LE, Vandegrift A, Fitzpatrick DM, Zent CS, Feldman T, Goy A, Claxton DF, Bachow SH, Kaur G, Svoboda J"
    }
}